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1. INTRODUCTION 
Traumatic spinal cord injury (TSCI) is a devastating and costly condition. TSCI 
typically leads to permanent loss of sensory and motor function. The severity of 
the condition is largely dependent on the neurological level as well as on the 
completeness of injury.  
About  12,000 to 20,000 people are suffering from TSCI in the United States 
each year (National Spinal Cord Injury Statistical Centre, 2010). This allows us 
to infer that every year more than 100,000 people acquire TSCI around the 
world. An estimated 2–3 million people worldwide are living with spinal cord 
injury (SCI) related disability (Wyndaele and Wyndaele, 2006). Moreover, a 
remarkable amount of patients (2.3–37.7%) die at the scene of the accident 
(Dryden et al., 2003; Griffin et al., 1985; Martins et al., 1998; Surkin et al., 
2000; Thurman et al., 1994) 
 Although the incidence of TSCI is relatively rare in comparison to traumatic 
brain injury, for example, it is an important problem for public health (Pérez et 
al., 2012; Tagliaferri et al., 2006; Wyndaele and Wyndaele, 2006). We must 
bear in mind that traumatic injuries are not inevitable. In order to facilitate 
injury prevention, standardised and comparable epidemiological data from 
every region of the world is necessary.  
The data about SCI in Eastern Europe is scarce. Considering that mortality 
due to injuries is several times higher in Estonia than in most European 
countries, the incidence of TSCI should also be high (Lai et al., 2009). The 
present study was designed to investigate the epidemiological situation of TSCI 
in Estonia, which would provide valuable data for healthcare planning.  
Depending on the type of nervous system lesion and its completeness and 
recovery, there may occur different patterns of cortical reorganisation. 
Functional magnetic resonance imaging (fMRI) is a potential surrogate marker 
of functional outcome (Freund et al., 2011; Freund et al., 2013). Cortical 
activation of patients with TSCI in the acute and subacute phases of TSCI was 
investigated in our study to observe temporal changes in the reorganisation of 
the sensorimotor cortex. 
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2. LITERATURE REVIEW 
Traumatic spinal cord injury (TSCI) may cause long-term disability which has a 
significant impact on quality of life and survival.  
 
 
2.1. Definition and diagnosis of TSCI 
TSCI is defined as an acute damage to the spinal cord caused by an external 
force with loss of motor and/or sensory function attributable to the level of 
spinal cord injury (SCI) (Kraus et al., 1975; American Spinal Injury Association 
(ASIA), 2011). The injury includes cauda equina and conus medullaris injuries, 
but not plexus lesions or injury to peripheral nerves outside the neural canal 
(Maynard et al.,1997). In addition to the motor and sensory deficit, autonomic 
nervous system impairment is also common (Claydon and Krassioukov, 2006). 
The clinical history of the patient is significant because it can provide 
information about the mechanism and severity of injury and predict outcome. 
The forces that damage the spinal cord are often great enough to cause injury to 
other organs, too. The most commonly associated injuries occur to the chest, the 
abdominal cavity and the brain (Benour  et al., 2013).  
The areas of the spinal cord most susceptible to injury are the cervical seg-
ments and the thoracolumbar junction (Burt, 2004). The incidence of cervical 
level TSCI has been reported to be 41.6–76.0%, the incidence of thoracic spine 
injuries, 19–34.6% and the incidence of lumbar spine injuries, 13.3–59.4% 
(Levi et al., 1995a; O’Connor, 2002; Pickett et al., 2006).  
Patients with TSCI may have concomitant vertebral column injuries. SCI 
without radiological abnormality (SCIWORA) is often encountered and intro-
duces the need for MRI to evaluate and detect any soft tissue or spinal cord 
injury (Yulesoy and Yuksel, 2008). Due to non-contiguous spinal fractures, the 
neurological level of injury does not match the vertebral level in 10–15% of 
TSCI cases. In addition to fractures at several levels of the spine, this may also 
be a sequel of cord stretching injuries (Silberstein and McLean, 1994). 
The minimal information necessary to document the neurologic status is the 
sensory and motor level on each side of the body and the ASIA Impairment 
Scale (Appendices A, B). 
In order to standardise the terms used all over the world, ASIA has proposed 
the following definitions of some fundamental terms (ASIA, 2011): 
A dermatome is the area of the skin innervated by the sensory axons within a 
segmental nerve (root). 
A myotome is defined as the collection of muscle fibres innervated by the 
motor axons within a segmental nerve (root). 
Sensory scores refer to the summary score of sensory function. The maxi-
mum is 56 points per side of the body for light touch and pin prick. Appre-
ciation of sensation is scored on a three-point scale (0, 1 or 2). 
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Motor score is a numerical summary score of motor function. The maximum 
score is 50 per side of the body. The strength of each muscle examined is 
graded on a six-point scale (0 to 5). 
The neurological level of injury indicates the most caudal segment of the 
spinal cord whose sensory and motor functions are normal bilaterally. By con-
vention, provided that sensory and motor functions are normal rostrally, the 
muscle function has to be at least a grade 3 for the neurological level of injury.  
The skeletal level is the most rostral level of the spinal column at which, on 
radiographic examination, the greatest vertebral damage is found. 
 
 
2.2. Classification of spinal cord injury 
A variety of SCI classification systems has been created. Today, the ASIA clas-
sification system is the most widely used among them (Teufack et al., 2013). 
The simplest method to classify a SCI is into complete and incomplete SCI 
(Teufack et al., 2013). The function of the lowest sacral segment (light touch or 
pin prick sensation at the S4-5 dermatome, deep anal pressure or voluntary anal 
sphincter contraction) determines the completeness of SCI. If partial sensory or 
motor function has preserved below the neurological level and involves the 
lowest sacral segment (S4-5), the lesion is defined as incomplete. Complete SCI 
is the term for the absence of sensory and motor functions in the lowest sacral 
segment (ASIA, 2011). 
The outcome for SCI patients correlates with the extent of neurological 
injury. Thus a reliable and reproducible method of classification of SCI is im-
portant.  
Over the years several grading systems have been used. The first classi-
fication system was published in 1969 by Frankel and colleagues. The main 
limitation of the Frankel grade was the fact that it did not clearly discriminate 
patients with different levels of motor function. This scale was not sensitive 
enough to reflect motor function improvement. The first system has been 
followed by many others (Teufack et al., 2013). The International Standards for 
Neurological Classification of Spinal Cord Injury was initially developed in 
1982 as the ASIA Standards for the Neurological Classification of Spinal Cord 
Injuries. Revisions were made in 1990, 1992, 1996, 2000 and 2011 (Kirshblum 
et al., 2011b). The ASIA Impairment Scale (AIS) designation is used in grading 
the degree of impairment and it is based on the Frankel scale but differs from it 
in several aspects. Sacral sensory spearing or voluntary anal sphincter 
contraction is added in order to differentiate between complete and incomplete 
injury. The ASIA scales C and D can be differentiated more clearly. 
The 2011 Revised American Spinal Injury Association Impairment Scale 
(Appendices A and B):  
A=Complete. No sensory or motor function preserved in the sacral segments 
S4-5. 
12 
B=Sensory incomplete. Sensory but not motor function is preserved below 
the neurological level and includes the sacral segments S4-5, and no motor 
function is preserved more than three levels below the motor level on either side 
of the body. 
C=Motor incomplete. Motor function is preserved below the neurological 
level, and more than half of the key muscles below the neurological level have a 
muscle grade 0 to 2. 
D=Motor incomplete. Motor function is preserved below the neurological 
level, and at least half of the key muscles below the neurological level have a 
muscle grade equal to or greater than 3. 
E=Normal. Sensory and motor functions are normal in all segments, and the 
patient had prior deficit. A person without a SCI is not assigned a AIS grade. 
 
 
2.3. Pathophysiology 
The spinal cord consists of longitudinally oriented spinal tracts surrounding 
central areas. The spinal cord can be divided into segments comprising sensory 
and motor neurons.  
The understanding of the nature  and process of pathophysiological events 
will lead to identification of therapeutic targets and recovery after SCI. In a 
laboratory animal the force of the trauma impact can be measured. On the other 
hand, in humans the secondary changes after TSCI cannot be directly observed 
or calculated (El Masri(y), 2006). Although an animal model of SCI cannot be 
directly extrapolated to humans with SCI, we can still learn the basic mecha-
nisms of the pathophysiology of SCI from it (Drazin et al., 2013). 
SCI is a biphasic event with the primary and secondary phases of injury. The 
primary event evolves the immediate changes caused by the initial mechanical 
force. The characteristics of the following secondary injury is dictated by the 
severity and location of the primary event. After TSCI the organism also 
attempts to elicit molecules that can aid in recovery following the injury. Stem 
cells, that may proliferate extensively following SCI, have been found in the 
adult mammalian spinal cord (Austin et al., 2013).  
Several new notions about the mechanisms of secondary injury have been 
described (McDonald and Sadowsky, 2002). Secondary changes that take place 
around the area of the spinal cord have been more widely studied. The patho-
physiology involves multiple mechanisms which occur concomitantly and are 
strongly interrelated (do Amaral, 2010). The changes are caused by vascular 
mechanisms, by ionic changes that lead to cellular dysfunction, formation of 
free radicals and by alteration of the cellular DNA. Biochemical mechanisms 
can be characterised by the release of glutamate and aspartate and provoke 
cellular death by an excitotoxity mechanism. Inflammation is produced by the 
release of arachidonic acid from cellular membrane. Vasoconstriction, pro-
duction of free radicals, apoptosis and cellular death are caused by inflam-
mation and by cellular mechanisms (do Amaral, 2010).  
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The pathophysiology is complex, however in order to allow new therapeutic 
approaches and facilitate treatment, physicians should be familiar with the 
mechanisms of the pathogenesis of SCI. The genesis of the primary lesion is 
important for the understanding of possible injury and prognosis. The secondary 
lesion is frequently potentially reversible and the understanding of its patho-
physiology may facilitate the treatment of SCI (do Amaral, 2010). 
 
 
2.4. Incidence of TSCI 
The incidence rates differ markedly between countries and it has also been 
found that the causes are dissimilar (Chiu et al., 2010; Hagen et al., 2012; Wyn-
daele and Wyndaele, 2006). Countries with similar economies tend to have 
similar incidences and features of SCI (Ackery et al., 2004). 
High incidence of TSCI in younger men results in enormous financial, 
emotional and physical costs for individuals, their families and society (Ackery 
et al., 2004). Depending on the employed methodology, the incidence rates of 
TSCI are different ranging from 2.3 per million in a Canadian and an Italian 
study to 83 per million in Alaska (Ahoniemi et al., 2008; Albert et al., 2005;  
Berg et al., 2011; Biering-Sørensen et al., 1990; Celani et al., 2001; Dincer et 
al., 1992; Divangolou and Levi, 2009; Dryden et al., 2003;  Espagnaq et al., 
2011; Exner and Meinecke, 2010; Hagen et al., 2010a; Jackson et al., 2004; 
Karacan et al., 2010;  Kondakov et al., 2002; Knútsdóttir et al., 2012; Lidal et 
al., 2007; Martins et al., 1998; O’Connor, 2002; O’Connor and Murray, 2006;  
Pagliacci et al., 2003; Pickett et al., 2006; Surkin et al., 2000; Tator et al., 1993; 
van Asbeck et al., 2000; van den Berg et al., 2010b; Warren et al., 1995). The 
incidence in the United States is much higher than in the rest of the world. In 
North America the incidence rate of 39 per million is more than twice of the 
Australian 15 per million and the European 16 per million (Cripps et al., 2010; 
NSCISC, 2010; O’Connor, 2002). But even within Europe the numbers are 
quite varying. The highest incidence has been reported from Portugal (57.8 per 
million population) (Martins et al., 1998) and Russia (44 per million) (Kon-
dakov et al., 2002), while it has been the lowest in Italy (2.3 per million) 
(Celani et al., 2001).  
Many studies underestimate the magnitude of the problem by excluding the 
patients who die at the scene of the accident, on arrival at the hospital, or during 
the first days (Ackery et al., 2004; Chiu et al., 2011; van den Berg et al., 
2010b). A number of studies have focused on patients in the rehabilitative 
phase, excluding deaths occurring in the acute or sub-acute phase of injury (van 
den Berg et al., 2010; Soden et al., 2000).  
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2.5. Risk factors for TSCI 
The incidence of TSCI is the lowest in the paediatric group and the highest for 
persons from 16 to 30 years of age (Teufack et al., 2013). The mean age at the 
time of injury is from 26.8 years in Turkey (Dincer et al., 1992) to 55.5 years in 
Oklahoma (Price et al., 1994). Several studies have reported that the average 
age at the time of injury is increasing, reflecting the increasing median age of 
the general population in many regions (DeVivo, 2012). Less developed 
countries display lower mean ages than more developed countries (Wyndeale 
and Wyndaele, 2006). For example, in the United States the mean age at the 
time of injury was 28.3 years during the 1970s and 37.1 years between 2005 
and 2008 (DeVivo et al., 2011). The proportion of new SCIs among persons 
older than 59 years of age increased from 4.6% in the 1970s to 13.2% between 
2005 and 2008 (DeVivo et al., 2011).  
Being a man is a potential risk factor for sustaining a SCI. All studies have 
found male preponderance. The male to female ratio ranges from 1:3 to 4.3:1 
among developed countries and 1.73:1 to 7.5:1 in developing countries (Cheng 
et al., 2008; Hoque et al., 1999; Masood et al., 2008; Pickett et al., 2006; 
Shingu et al., 1994; ).  
The incidence rates are higher for the blacks than for the whites. The incidence 
rate ratio of the whites to the blacks is 1.4:2.0 overall (Teufack et al., 2013).  
SCI occurs most frequently on weekends and during the warm weather months, 
which is attributable to certain sport activities, for example, diving and surfing 
(Teufack et al., 2013).  
Alcohol is an important risk factor not to be forgotten. Twenty-two to fifty 
per cent of new SCI cases involve alcohol use or their blood alcohol test is 
positive after the injury (Teufack et al., 2013). People face a substantially 
elevated risk for SCI on the days when they drink alcohol (Levy et al., 2004). A 
large percentage of fatal injuries are connected to alcohol drinking. The alcohol-
attributable mortality rate in the EU-10 (new countries in Central and Eastern 
Europe, including Estonia) is more than twice as high as in the EU-15 for men 
and 40% higher for women. In the Baltic countries, the overall alcohol-attri-
butable mortality is more than 4 times higher for men and 3 times higher for 
women than in the EU-15 (Rehm et al., 2011). The drinking pattern in this 
region is binge-drinking, which is the most hazardous pattern (McKee and Brit-
ton, 1998; Popova et al., 2007). Alcohol has also been found to be the strongest 
risk factor for TBI followed by completeness of TSCI (Hagen et al., 2010a).   
 
 
2.6. Causes of TSCI 
The aetiology of injury varies. The causes are often grouped into 5 categories: 
motor vehicle accidents, violence, sports/recreational activities, falls and all 
other causes. In most countries traffic accident is the leading cause of injury 
(Ackery et al., 2004; Chiu et al., 2010; Cripps et al., 2011; Hagen et al., 2012). 
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Falls is typically the second cause of TSCI, and has shown a clear increase over 
the years (Kennedy et al., 2012).  
According to the National Spinal Cord Injury Statistical Centre (NSCISC) 
database for 2005 to 2010, 40.4% of injuries were caused by traffic accidents, 
27.9% by falls, 15.0% by violence, 8.4% by other causes, 8.0% by sport acci-
dents and in 0.1% of cases the cause of injury was unknown (NSCISC, 2010).  
Falls-related SCI rates are high in Western Europe, especially in the 
Northern countries (Ahoniemi et al., 2008; Hagen et al., 2010a; Hartkopp et al., 
1997). However, these countries are known for one of the highest proportions of 
persons older than 60 years in Europe, too. Elderly people are more prone to 
falls. Not all falls will result in injury, but 20% require medical attention, 5% 
result in a fracture, and 5–10% result in other serious injuries (Kannus et al., 
2007). As falls are common events in the elderly, there has been reported a 
bimodal distribution of TSCI incidence rates. The first peak occurs among the 
young, the second peak after the age of 60 years (Berg et al., 2011; Dryden et 
al., 2003). Kennedy and colleagues demonstrated that in their study the patients 
who sustained TSCI due falling were 8.2 years older than those within the non-
falls group. Also they showed that the individuals in the falls group had 
significantly poorer rehabilitation outcomes in bladder management, mobility 
and discharge compared to those in the non-falls group (Kennedy et al., 2013). 
In the NSCISC database TSCI recorded as a result of falls accounted for 16.5% 
from 1973 to 1979, for 20% from 1990 to 1994, and finally for 27.9% from 
2005 to 2010 (NSCISC, 2010).  
Violence has been documented as a frequent cause of TSCI in South-Africa 
and the United States (US). On the other hand, in Europe violence is the cause 
of TSCI in less than 5% of cases (Hagen et al., 2012). Acts of violence are 
usually reported as the fourth leading aetiology of TSCI. In the state of Okla-
homa in the US, the incidence of violence is as common as the incidence of 
motor vehicle accidents among the black population (Price et al., 1994). Fortu-
nately, the incidence of violence has declined dramatically since the 1990s 
(DeVivo, 2012). 
Sports accidents are common among young individuals. The most frequent 
fields are diving, gymnastics and rugby (Chiu et al., 2010; Cripps et al., 2011; 
van den Berg et al., 2010). Sports-related injuries have also declined from 
14.2% in the 1970s to 10% since 2000 (DeVivo, 2012).  
Like in the incidence, there are also large variations in the aetiology of injury 
in different countries. An explanation may be geographic and cultural diffe-
rences, but the methods and study designs used in these areas are not the same, 
which may also account for the variance (Hagen et al., 2012). 
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2.7. Severity of injury 
In addition to the lesion level, TSCI is classified as complete and incomplete 
(Maynard et al., 1997). The severity of TSCI has been measured by combining 
the neurological level and extent of injury into complete tetraplegia, incomplete 
tetraplegia, complete paraplegia and incomplete paraplegia (Ahoniemi et al., 
2008; Hagen et al., 2010a; Ning et al., 2010). Recently, the Executive Com-
mittee for the International Spinal Cord Injury Data Sets Committee has recom-
mended to report the severity of injury under five categories: injury level at 
segments C1-4 and AIS A, B or C; C5-8 AIS A, B or C; T1-S5 AIS A, B or C; 
AIS D at any injury level; and ventilator dependent at any injury level (ASIA, 
2011; DeVivo et al., 2011; Appendix A, B). 
Similarly to the aetiological factors (the rising number of TSCI due to falls), 
there are also possible trends in the severity of injury. The proportion of 
tetraplegia is rising as well as incomplete injuries (Ahoniemi et al., 2008; 
DeVivo et al., 2011; DeVivo 2012; O’Connor 2005). One explanation for that 
trend may be the fact that older persons are more likely to be injured through 
falls, which will result in incomplete SCI. Moreover, as the patients have more 
chances to reach hospital alive, the percentages of C1-C4 injuries are in-
creasing, as well as is ventilator dependency (DeVivo, 2012).  
Causes of TSCI also have an important role in determining preserved neuro-
logical function. For example, up to 88% of recreational sports-related SCIs 
result in tetraplegia (Jackson et al., 2004). At the same time, violence-related 
SCIs mostly result in paraplegia (Jackson et al., 2004). 
 
 
2.8. Associated injuries 
The International SCI Standards and Data Sets Committee has recommended to 
document the following associated injuries in SCI (De Vivo et al., 2006): 
 Moderate to severe traumatic brain injury (TBI) 
 Extraspinal fractures requiring surgery 
 Severe facial injuries affecting sense organs 
 Major chest injury requiring chest tube or mechanical ventilation 
 Traumatic amputation of an arm or a leg 
 Severe haemorrhages 
 Damage to any internal organs requiring surgery 
When a person sustains both a TSCI and a concomitant brain injury, morbidity 
is increased and quality of life is reduced, which has also major influence on the 
outcome of rehabilitation (Hagen et al., 2010a; Macciocchi et al., 2004). A 
combination of TSCI and TBI found in different studies has been 16% to 74% 
(Macciocchi et al., 2007; Tolonen et al., 2007). TBI is more frequent in patients 
who sustain a traffic accident or a fall. The cervical level of SCI is also 
associated with higher TBI rates (Macciocchi et al., 2008; Hagen et al., 2012). 
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Failing to diagnose a TBI will negatively impact TSCI rehabilitation outcomes 
or even lead to death. 
 
 
2.9. Survival and mortality of TSCI 
Life expectancy of individuals with TSCI has improved significantly during the 
last decades. Nevertheless, patients with TSCI die earlier than their contem-
poraries in general population.  
The median life expectancy is 33 years after injury (DeVivo et al., 1999). A 
systematic review conducted by van den Berg and colleagues (van den Berg et 
al, 2010) showed that median survival ranges from 35.4 days in a study 
including pre-hospital death (Martins et al., 1998) to 35.6 years (Lhéritier et al., 
2001). 
Typically, as most individuals with TSCI are young men in their twenties, 
the mortality risk is also higher for men (Strauss et al., 2000; DeVivo et al., 
1999; O’Connor 2005; Espagnacq et al., 2011; Krause et al., 2008). A Nor-
wegian study reported an increased risk of dying among patients with TSCI, 
with a standardised mortality ratio (SMR) of 2.88 for women and 1.72 for men 
(Hagen et al., 2010b). Reduced life expectancy has also been found in Finland 
(Ahoniemi et al., 2011) and Denmark (Hartkopp et al., 1997).  
Crude SMR among the patients with TSCI is 3 times higher than in general 
population. The period shortly after TSCI poses an especially high risk of death. 
The mortality risk is extremely increased during the first two years after the 
injury (van den Berg et al., 2010). DeVivo and colleagues have shown that the 
survival rates in the first year after SCI are improving. However, unlike in 
general population, no such reduction has been found in long-term annual 
mortality rates (DeVivo et al., 1999, DeVivo et al., 2007, Strauss et al., 2006). 
Survival is considered to be strongly related to neurological level, extent of 
lesion, age at injury and year of injury (van den Berg et al., 2010). Also, 
patients with more comorbid conditions have showed a significantly elevated 
risk of dying (Selassie et al., 2012). 
The causes of death are the diseases or injuries that directly or indirectly 
cause deaths. Until the mid-1970s, urinary tract complications were reported to 
be the most frequent causes of death among TSCI patients. Today deaths are 
most often caused by respiratory complications. Other risk factors for death are 
suicides, cardiovascular diseases and septicaemia (van den Berg et al., 2010; 
Garshick et al., 2005; Hagen et al., 2010b; Hartkopp et al., 1997; Lidal et al., 
2007). 
 
2.10. Management of TSCI 
Treatment of SCI has evolved over the past decades. It is based on the foun-
dation laid by Sir Ludwig Gutmann, who started to treat “hopeless” cases of 
spinal injuries during World War II (Kakulas, 2004).  
18 
Adequate perfusion and oxygenation of the injured nervous tissue are im-
portant to lessen the secondary injury and to optimise recovery. Specialised 
neurocritical care units provide the needed environment for treating patients 
with TSCI. 
As the direct compression of neural elements by bone fractures and disc 
material is a significant mechanism of the initial injury, removal of these frag-
ments is an option to decompress the spinal cord. Still, early surgery remains 
controversial, unless canal integrity is severely compromised (McDonald and 
Sadowsky, 2002). Prior to the 1970s, the only operative treatment was lami-
nectomy, that was avoided because of the abnormally high incidence of neuro-
logical complications. Today, it has been found that surgery accelerates the 
rehabilitation process, shortens immobilisation, and decreases mortality and 
medical costs (Niazi et al., 2013). Early operative intervention can also decrease 
the amount of secondary complications (McKinley et al., 2004). A recent multi-
centre international prospective cohort study (Surgical Timing in Acute Spinal 
Cord Injury Study: STASCIS) in adults with cervical SCI concluded that 
decompression before 24 hours after SCI can be performed safely and is 
associated with better neurological outcome (Fehlings et al., 2012).  
The arguments against surgery are increased risk of infections, bleeding, 
hypoxia, hypotension. Yet increasingly more specialists conclude that early 
decompression – within 24 hours after injury – is an option for medically stable 
patients (Niazi et al., 2013). 
Among the possible non-surgical treatments is traction that can be used 
alone or as a preoperative treatment. The halo and Gardner-Wells tongs can be 
used for the setting of cervical fractures, subluxations or dislocations (Lerman 
et al., 1994). 
The first proven pharmacological treatment for TSCI was high-dose methyl-
prednisolone (MPSS). It was reported to reduce swelling, inflammation and 
accumulation of free radicals when given within 8 hours of trauma (Bracken et 
al., 1984; Bracken et al., 1990; Bracken et al., 1997; McDonald and Sadowsky, 
2002). The MPSS inhibits lipid peroxydation and hence preserves neurons, 
axons, myelin and glial cells (Marchan et al., 2013). On the other hand, it has 
been shown that MPSS inhibits axonal sprouting and synaptogenesis. High-dose 
MPSS administration may have serious negative effects by increasing the 
incidence of gastrointestinal bleeding, wound infection, pulmonary embolism, 
pneumonia and death (Hulbert, 2000). Given the risks and benefits, the 
published evidence does not support using high-dose MPSS as a standard 
treatment in acute SCI (Marchan et al., 2013). 
Some studies have shown chondroitinase ABC to promote regeneration of 
corticospinal tract axons. Nogo-A antibodies enhance axon collateral and 
regenerative sprouting. Different neurotrophins (nerve growth factor (NGF), 
brain-derived neurotrophic factors (BDNF), neurotrophin 3 (NT-3)) are capable 
of supporting survival of injured neurons (Onifer et al., 2011). Cellular replace-
ment has been widely investigated. These cell types include Schwann cells, 
olfactory ensheathing glial cells, embryonic and adult stem/progenitor cells, 
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fate-restricted neural/glial precursor cells, and bone-marrow stromal cells 
(Tetzlaff et al. 2011). The actual mechanisms of how transplanted cells exert 
their beneficial effect are poorly understood, which may pose several ethical, 
logistic and safety problems (Tetzlaff et al. 2011). Neuroplasticity may also 
have negative consequences when the re-wiring leads to pain, autonomic 
dysreflexia or other negative sequellae of SCI (Brown and Weaver, 2012). 
 
 
2.11. Complications after TSCI 
Owing to the improved life expectancy of patients with TSCI, a variety of 
distressing health conditions and complications can occur in the acute phase or 
long time after TSCI. Such conditions can cause substantial medical and finan-
cial problems, but also psychosocial difficulties. These complications lead to 
increased health care utilisation and costs (Burns et al., 2013), and the start of 
rehabilitation may be delayed or interfered by different complications (Haisma 
et al., 2007).  
In addition to motor and sensor deficits, spinal cord injury implies serious 
disturbances in autonomic nervous system function. The severity of these 
dysfunctions depends on the level and completeness of injury of the spinal cord. 
Individuals with cervical or upper thoracic (≤Th6) spinal cord injury experience 
episodes of hypertension (autonomic dysreflexia) or falls in blood pressure 
during a positional change (orthostatic hypotension). Acute SCI can provoke 
altered cardiac electrophysiology and increase susceptibility to cardiac arrhyth–
mias (especially bradycardia). Subjects with tetraplegia also demonstrate 
elevated vagal activity with reduction in baseline airway calibre, and findings 
attributed to loss of symphathetic innervation to the lungs.  In addition, patients 
with major injury have thermoregulation disturbances caused by loss of 
symphathetic control of more than half of the body (Sabre et al., 2011).  
Respiratory complications are a leading cause of mortality and morbidity 
after TSCI. Cervical TSCI provide paralysis of respiratory muscles: these 
patients are at a higher risk for developing pneumonia, atelectasis and respi-
ratory failure. Long-term preventive care is mandatory, which includes chest 
physiotherapy, assisted coughing, and influenza and pneumococcal vaccinations 
(Burns et al., 2013; Jackson et al., 1994).  
After TSCI the risk factors for coronary artery disease increase, occur earlier 
and more often than in able-bodied persons (Bauman and Spungen, 2008). 
Inactivity also predisposes to metabolic abnormalities, insulin resistance and 
may lead to hyperinsulinaemia (Bauman and Spungen, 1994). Higher pre–
valence of coronary artery calcifications has been demonstrated in persons with 
TSCI (Bauman and Spungen, 2008).  
Deep vein thrombosis is an important complication in the acute phase of 
TSCI. The incidence of deep vein thrombosis in the acute phase has been 
reported to be 10 to 100% among the patients without prophylaxis and 0 to 7% 
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among those with prophylaxis (Agarwal and Mathur, 2009; Casas et al., 1977; 
Green et al., 1998; Saraf et al., 2007; Todd et al., 1976).  
Important secondary health conditions are the neurogenic bladder and bowel 
dysfunction. The clinical manifestations of bladder dysfunction in the lower 
motor neuron syndrome are urinary retention and/or incomplete bladder 
emptying (Potter et al., 2006). Detrusor-sphincter dyssynergia and involuntary, 
reflective voiding are caused by a loss of cortical inhibition over reflective 
voiding in the upper motor neuron syndrome (Potter et al., 2006).  
Recurrent urinary tract complications, as well as renal and bladder calculi 
are common after SCI. The detrusor-sphincter dyssynergia increases the intra-
vesical pressure that in turn leads to vesicouretral reflux, hydronephrosis, 
recurrent pyelonephritis and progressive deterioration in renal function (Burns 
et al., 2013). In the past, renal failure was the leading cause of death following 
SCI. But with the improved management of  the neuropathic bladder and 
urinary tract infections, the incidence of renal failure has decreased significantly  
(Burns et al., 2013; Potter, 2006). Gastric dilatation and ileus are common in the 
acute phase of SCI. Colonic diverticulae and haemorrhoids are caused by 
constipation (Chung and Emmanuel, 2006).  
Heterotopic ossification is a well-known secondary complication of SCI 
characterised by the formation of new ectopic bone in soft tissue (van Kuijk et 
al., 2002). SCI patients report more of different pains, and more fatigue, anxiety 
and insomnia (Levi et al., 1995b). Aside from causing pain, spasticity may 
diminish patient’s quality of life by preventing to perform personal hygiene 
procedures, by interfering with sleep, and by impending rehabilitation efforts 
and function (Burns et al., 2013; Rekand et al., 2012; Sköld et al., 1999). 
Lack of mechanical stress gives rise to loss of bony mass (Werhagen et al., 
2012). The lack of sensation causes pressure ulcers, which in turn may be 
complicated by cellulitis, osteomyelitis, sepsis and deconditioning (Burns et al., 
2013). 
 
 
2.12. Recovery, prognosis and reorganisation  
of the brain after TSCI 
Not long ago a patient with TSCI was treated as someone with no prognosis and 
was labelled with the expression “not to be treated” (Kakulas, 2004). For a  
revolutionary change in the treatment of SCI, we are indebted to Sir Ludwig 
Guttmann from the United Kingdom and Sir George Bedbrook from Australia. 
According to the severity and mechanism of the lesion, motor, sensory and 
autonomic functions can spontaneously return or be recovered to a varying 
extent (Onifer et al., 2011). Even patients without initial motor or sensory 
function below the injury may still achieve excellent recovery. The key factors 
for recovery are: 
 completeness or incompleteness of injury 
 level of injury 
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 initial strength of muscles in the first caudal level below the injury 
 presence of sensation in the sacral segments (Fawcett et al., 2013) 
The most important predictor of improved outcome is sacral sensation 72 hours 
to 1 week after injury (McDonald and Sadowsky, 2002; Marino et al., 1999). 
Incomplete injuries will recover with a wider range. The greatest gains in motor 
skills occur in the first 3 months, with the most of recovery by 9 months. How-
ever, additional recovery can occur up to 12 to 18 months post-SCI (Fawcett et 
al., 2013).  
The changes that will take place are summarised under the term plasticity. 
This phenomenon can be found elsewhere in the neuraxis. It is now possible to 
conclude that adult central as well as peripheral nervous systems respond to 
TSCI with plasticity (Onifer et al., 2011).  
Depending on the type of nervous system lesion, completeness and recovery, 
different patterns of cortical reorganisation may occur (Kokotilo et al., 2009a). 
Earlier, body cortical representations were believed to be stable. Within the last 
20 years recent advances in neuroimaging and brain mapping have shown that 
the cortex may adapt to the environment (Bareyre, 2008; Kokotilo et al., 2009a; 
Pascual-Leone et al., 2005). There are different endogenous recovery strategies 
and spontaneous functional recovery may take place in 40% of SCI patients 
(Bareyre, 2008; Tsung and Fassett, 2011). 
Although spinal cord injury does not affect the brain, changes in the brain 
function of TSCI patients have been identified in different studies. Several 
analysts have expressed doubts about the exact pattern of changes after TSCI 
because of varying and even conflicting results (Kokotilo et al., 2009a).  
It is worth recognising that reorganisation will not be similar in individuals 
with paraplegia compared to those with tetraplegia. A growing body of brain 
reorganisation studies has been performed on paraplegics. Only a few studies 
have investigated cortical reorganisation after cervical TSCI (Curt et al., 2002; 
Jurkiewicz et al., 2007; Jurkiewicz et al., 2010; Mikulis et al., 2002). Two 
studies have been performed to report the temporal evolution of cortical sensori-
motor activity after TSCI (Jurkiewicz et al., 2007; Jurkiewicz et al., 2010).  The 
first study, within which TSCI patients with motor recovery were studied, 
detected progressive enlargement in the primary motor cortex and decreased 
activation in the associated cortical areas was detected (Jurkiewicz et al., 2007). 
When these authors studied 4 tetraplegic individuals whose paralysis persisted, 
activation was extensive in the associated areas in the early post-injury period 
but progressed toward no activation by the end of the first year (Jurkiewicz et 
al., 2010). 
Different findings have been reported concerning brain activation. Still, it is 
difficult to determine the influence of SCI on brain reorganisation because 
subjects have variable lesion locations and completeness of injury, as well as 
the length of time after injury. Increase in activation magnitude have been found 
in several researches (Alkadhi et al., 2005; Bruehlmeier et al., 1998; Curt et al., 
2002; Hotz-Boendermaker et al., 2008). The cortical areas with increased 
activation were the bilateral primary motor cortex, supplementary motor area, 
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premotor area, cingulate motor area, parietal cortex, contralateral primary 
somatosensory cortex (Figure 1). In contrast, some studies have not found diffe-
rences in brain activation between patients with SCI and controls (Castro et al., 
2007; Halder et al., 2006; Mattia et al., 2006). Two studies have reported 
reduced activation in individuals with SCI (Cramer et al., 2005; Sabbah et al., 
2002).  
 
 
 
 
Figure 1. The brain areas with increased activation during motor tasks in spinal cord 
injury compared to controls. Increased activation has been found in bilateral primary 
motor cortex (M1), primary somatosensory cortex (S1), supplementary motor area 
(SMA), premotor area (PM), cingulated motor area (CMA), parietal cortex, cerebellum, 
thalamus, and basal ganglia. (A) Medial view (B) Lateral view (Kokotilo et al., 2009a) 
(with permission from Mary Ann Liebert, Inc.). 
 
 
Two types of spatial shift have been observed: medial and posterior (Kokotilo et 
al., 2009a) (Figure 2). The explanation for the posterior shift was the direction 
of the deafferented limb representation (Green et al., 1999). Turner et al. have 
postulated that it could be possible that a posterior shift relates to increased 
activation in the somatosensory cortex due to neuropathic pain experienced by 
some people with SCI. The shift in the direction of the deafferented limb 
representation in M1 was found by 3 groups (Bruehlmeier et al., 1998; Lotze et 
al., 1999; Mikulis et al., 2002) and it can be explained by chronicity of SCI. For 
example, Mikulis et al. studied tetraplegic TSCI patients in the chronic phase 
and showed that when these patients moved their tongue, the primary motor 
cortex activation was shifted medially and posteriorly into the upper limb 
representation region (Mikulis et al., 2002). Several investigators have sug-
gested that a similar shift takes place among paralyzed patients when they move 
their hand (Kokotilo et al., 2009a; Curt et al., 2002; Lotze et al., 1999). The 
possible causes of the changes are destructed sensorimotor tracts, disruption of 
23 
the lateral inhibitory network in the cortex, and modification of neuronal 
activity (Mikulis et al., 2002; Streletz, 1995). 
Patients with TSCI and stroke share several aspects of brain reorganisation 
following injury (Kokotilo et al., 2009b). The more severe is the hand motor 
deficit, the greater is the shift of primary motor cortex activation towards the 
contralateral hemisphere balance.   
 
 
 
 
Figure 2. Two types of spatial shift described  in activation during a motor task in 
patients with spinal cord injury (A) Posterior shift of activation towards primary 
somatosensory cortex during an upper limb motor task (activation represented by 
shading). (B) Activation of upper limb movement is shifted in the direction of the 
deafferented upper/lower limb representation in para/tetraplegic SCI subjects (Kokotilo 
et al., 2009a) (with permission from Mary Ann Liebert, Inc.). 
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3. AIMS OF THE STUDY 
1. To evaluate the incidence and temporal trends of TSCI in Estonia from 1997 
to 2007 (Paper I) 
2. To analyse the demographic and clinical characteristics of an a population 
based cohort of Estonia from 1997 to 2007 (Paper I) 
3. To compare the incidence and survival rates of TSCI in Estonia with those in 
Western-Norway (Paper II) 
4. To study the mortality and causes of acute and long-term death among TSCI 
victims (Paper III) 
5. To establish cortical activation patterns after cervical TSCI within the first 
year after TSCI (Paper IV) 
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4. SUBJECTS AND METHODS 
4.1. Study design 
Papers I and III 
The study design was retrospective cohort study including TSCI cases in 
Estonia between January 1, 1997 and December 31, 2007. 
Paper II 
Retrospective population based study in two Norwegian counties (Hordaland 
and Sogn og Fjordane) and in the whole Estonia from 1997 to 2001.  
Paper IV 
Case series study. Functional magnetic resonance imaging (fMRI) was used to 
study 6 TSCI patients during the first year after the injury and 12 healthy sub-
jects at Tartu University Hospital. 
 
 
4.2. Collection of data and case ascertainment 
Organisation of TSCI care in Estonia 
There are no spinal cord units established in Estonia. As a rule, most patients 
with TSCI in Estonia are acutely admitted to the Departments of Neurosurgery 
of the North Estonia Medical Centre or Tartu University Hospital where the 
patients are evaluated and treated neurosurgically, if needed. Children are 
usually treated in Tallinn Children's Hospital or Tartu University Hospital. 
Patients who are medically stable and for whom neurosurgical management 
is not indicated are treated at central or general hospitals.  
 
Papers I and III 
Case definition 
Several overlapping methods of case ascertainment were used to minimize 
possible missing cases. We selected the cases under the International Classi-
fication of Disease-10 (ICD-10) diagnosis codes suggesting TSCI (Table 1). 
Medical records with the diagnosis codes suggesting spinal fractures were also 
reviewed in order not to lose any relevant cases. Patients from all age-groups, 
including children, were recorded. 
The inclusion criteria were: 1) traumatic spinal cord or cauda equina injury 
with neurological deficit found at discharge 2) permanent resident of Estonia at 
the time of injury. Patients with only transient neurological symptoms (varying 
degrees of motor or sensory deficit) that had lasted less than seven days, and/or 
pain, or non-traumatic injury, were excluded. Fatal cases before hospitalization 
were not included. 
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Table 1. ICD-10 codes used to identify traumatic spinal cord injuries in Estonia, 1997–
2007. 
 
ICD-10 
G82 Paraplegia and tetraplegia 
S12.0 Fracture of first cervical vertebra 
S12.1 Fracture of second cervical vertebra 
S12.2 Fracture of other specified cervical vertebra 
S12.7 Multiple fractures of cervical spine 
S13.0 Traumatic rupture of cervical intervertebral disk 
S13.2 Dislocation of other and unspecified parts of neck 
S13.4 Sprain and strain of cervical spine 
S14.0 Concussion and edema of cervical spinal cord 
S14.1 Other and unspecified injuries of cervical spinal cord 
S22.0 Fracture of thoracic vertebra 
S23.0 Traumatic rupture of thoracic intervertebral disc 
S23.1 Dislocation of thoracic vertebra 
S24.0 Concussion and edema of thoracic spinal cord 
S24.1 Other and unspecified injuries of thoracic spinal cord 
S32.0 Fracture of lumbar vertebra 
S33.0 Traumatic rupture of lumbar intervertebral disc 
S33.1 Dislocation of lumbar vertebra 
S34.0 Concussion and edema of lumbar spinal cord 
S34.1 Other injury of lumbar spinal cord 
S34.3 Injury of cauda equina 
T06.0 Injuries of brain and cranial nerves with injuries of nerves and spinal cord at 
neck level 
T06.1 Injuries of nerves and spinal cord involving other multiple body regions 
T09.3 Injury of spinal cord, level unspecified 
T91.1 Sequelae of injuries, of poisoning and of other consequences of external 
causes – Sequelae of injuries of neck and trunk – Sequelae of fracture of spine 
T91.3 Sequelae of injuries, of poisoning and of other consequences of external 
causes – Sequelae of injuries of neck and trunk – Sequelae of injury of spinal 
cord 
 
Abbreviation: ICD-10, International Classification of Diseases, Tenth revision. 
 
 
Data collection 
For the purpose of this study, all medical records of the patients with the diag-
nosis of TSCI or suspected TSCI in Departments of Neurosurgery of the North 
Estonia Medical Centre or Tartu University Hospital and in all Estonian rehabi-
litation hospitals, in central and general hospitals were also looked through. 
About 3000 medical records of the patients with possible TSCI diagnosis 
were retrospectively reviewed. Altogether, medical records from 22 Estonian 
hospitals (3 regional, 3 rehabilitation, 4 central and 12 general hospitals) were 
reviewed and data on all cases of TSCI were abstracted. 
Information about whether the person was alive or dead by December 31, 
2011 was obtained from Statistics Estonia (Statistics Estonia, www.stat.ee). The 
27 
cases were linked with the data from the Cause of Death Registry. The cases 
were matched by the identity codes. 
The coding system used was the 10th version of the International Classi-
fication of Diseases (ICD). The following 14 categories of the European ICD-
10 Causes of Death short list (European Communities, 2009) were used for this 
study: (1) sepsis, (2) neoplasm, (3) endocrine, nutritional and metabolic 
diseases, (4) mental and behavioural disorders, (5) diseases of the nervous 
system, (6) diseases of the circulatory system, (7) diseases of the respiratory 
tract, (8) diseases of the digestive system, (9) diseases of the skin and 
subcutaneous tissue, (10) diseases of the musculoskeletal system, (11) diseases 
of the genitourinary system, (12) external causes of injury and poisoning, (13) 
suicide, (14) other disorders. Information concerning the date of death and the 
immediate and underlying cause of death was registered. Information about the 
cause-specific mortality rates for the general population was obtained from 
Statistics Estonia (Statistics Estonia, www.stat.ee). 
The patients in the Paper I and II were divided into eight age-groups 
according to the age at the time of injury (0–19, 20–29, 30–39, 40–49, 50–59, 
60–69, 70–79, 80+ years). By the time of publishing Paper III, authors were 
requested to use 15 year increments when grouping the patients: 0–15, 16–30, 
31–45, 46–60, 61–75, 76+ (DeVivo et al., 2011; Wyndaele, 2012).  
As it has been found that the mortality risk is increased during the first two 
years after the injury (Middleton et al., 2012; O’Connor, 2005; Strauss et al., 
2000), the dead patients in the study III were divided into two groups: those 
who died during the first two years and those who died thereafter.  
 
Paper II 
The scientific collaboration between the Department of Neurology at the 
Universities of Tartu (Estonia) and Bergen (Norway), uniform data collection, 
and stable population in both Estonia and Norway gave an excellent opportunity 
to compare the incidence, characteristics and mortality of TSCI in Western 
Norway and Estonia. 
The data collection system in Estonia and Norway was uniform. Medical 
records from all hospitals in these areas (8 Norwegian and 22 Estonian 
hospitals) between 1997 and 2001 were scrutinized. We used the same proce-
dures of patient identification by reviewing the records of all patients with a 
diagnostic code of the International Classification of Diseases 10th version 
(ICD-10) suggesting a traumatic spinal cord injury or a fracture of the spinal 
column at discharge.  
The causes of injury were classified into 4 groups: motor vehicle accidents 
(MVA), falls, sport injuries and other injuries (DeVivo et al., 2006). The extent 
of injury was classified according to the American Spinal Injury Association 
Impairment Scale (AIS) (Marino et al., 1999). The patients were stratified 
retrospectively according to the level of injury and also depending on complete 
or incomplete injury. The patients were grouped according to concomitant trau-
matic brain injury and use of alcohol prior to the injury. When examining the 
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standardised mortality ratio the patients were also grouped into three age-groups 
according to age at time of injury; 0–29 years, 30–59 years and older than 60 
years. 
Records of TSCI related deaths before hospitalisation were not available for 
either of the countries. 
All the patients were followed until death or 14th October, 2011. The date of 
death was obtained from the National Population Registers of Norway and 
Estonia.  
 
Paper IV 
The patients consecutively admitted to Tartu University Hospital from May 
2010 to August 2010 with acute TSCI were studied repeatedly by functional 
magnetic resonance imaging (fMRI) at 20.8 ± 6.7, 111.3 ± 21.9 and 376 ± 26.3 
days after the injury. Six right-handed tetraplegic male patients (mean age  
27.3 ± 10.9 years, range 18–41 years) were included to the study.  
Twelve age- and gender matched healthy controls (mean age 27.1 ± 10.1 
years, range 18–42 years) were studied at a single point of time and 7 controls 
were studied on 2 occasions (353.7 ± 50.5 days between the studies).  
The inclusion criteria were tetraplegia due to cervical TSCI. The TSCI 
patients had to be medically stable and able to give informed consent before the 
study. We excluded patients with traumatic brain injury, patients with a pre-
vious history of seizures and those who had contra-indications to MRI. Only 
patients with a neurological deficit lasting more than one week were included.  
 
 
4.3. Clinical data 
Papers I, II and III 
Demographic data, length of admission, level of injury, extent of injury 
according to the American Spinal Injury Association Impairment Scale (AIS), 
cause of injury and alcohol consumption associated with trauma, and the 
presence of diagnosis of spinal fracture were recorded from medical records 
(Maynard et al., 1997). In Papers I and III the causes of TSCI were divided into 
6 groups (sports and leisure activities, assaults, transport activities, falls, other 
traumatic causes, unknown) as suggested by the Executive Committee for the 
International Spinal Cord Injury Data Sets Committees (DeVivo et al., 2006). 
Paper II comprised 4 groups (motor vehicle accidents, falls, sport injuries and 
other injuries).  
Severity of injury was reported by 4 categories according to the recent 
recommendations by the Executive Committee for the Development of the 
International Spinal Cord Injury Data Sets: C1-4 AIS A, B or C; C5-8 AIS A, B 
or C; T1-S5 AIS A, B or C and AIS D at any injury level. Due to the small 
number of ventilator dependent patients, they were analysed together with the 
C1-4 AIS A, B, C patients (Appendix A, B; DeVivo et al., 2011).  
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Alcohol consumption prior to a TSCI was registered when on admission to 
the hospital signs of alcohol were detected in the blood or when alcohol 
consumption before the trauma was recorded in medical documents.  
 
Paper IV 
The extent of injury was estimated according to the American Spinal Injury 
Association (ASIA) Impairment Scale (AIS) (Appendix A, B; DeVivo et al., 
2011). The patients were classified according to their motor level of injury (C5, 
C6 and C7).  Recovery of motor function occurred in 3 patients (Table 12).  
Patient No 1 was hospitalised with severe tetraplegia after TCSI. The first 
imaging was performed 19 days after the trauma, when significant recovery had 
occurred. Patient No 5 was moved from the complete injury group to the in-
complete injury group because sensation in the sacral segments improved over 
the course of the first year. However, he remained in the motor complete group 
of injury in this study.  
 
 
4.4. Imaging procedures and data processing 
All subjects in the fMRI study were informed about the study, their tasks and 
the length of the imaging before the procedure. Each activation experiment 
consisted of a 40 s period of rest, followed by a 40 s period of movement, both 
repeated three times. The individuals were trained to perform the movements at 
a frequency of 1 Hz. 
During the fMRI study the individuals performed active simple test-retest 
cycles of 1) flexion/extension of the right hand fingers; 2) flexion/extension of 
the right ankle. Motor tasks were continuously visually monitored and counted 
by an observer. The number of movements in each block was summed, and 
divided by the total number (3) of movement blocks.  
All patients were able to perform some hand movement but in patients with 
complete injury the observed movement was wrist movement. Ankle movement 
was not feasible for half of the patients and their lower limb motor score 
remained 0 (Table 12). However, all patients attempted to move ankle.  
Images were obtained on a 1.5 T clinical whole body MR scanner (Magne-
tom Symphony; Siemens Medical Systems, Erlangen, Germany). Prior to 
functional scans, a high resolution T1 weighted anatomical image was obtained 
with the gradient echo, fast low-angle shot (FLASH) sequence (repetition time 
(TR)=12 ms, echo time (TE)=5.68 ms, flip angle 15˚, resolution 224×256, voxel 
size 1×1×1 mm3, 176 sagittal planes). Functional T2* weighted images were 
obtained using the gradient echo planar imaging (EPI) sequence (TR=4 s, 
TE=50 ms, flip angle 90˚, resolution 64×64, voxel size 3×3×3 mm3, slice gap 
0.75 mm, 36 axial planes, interleaved scan). Altogether 60 whole brain functio-
nal images were obtained for each patient and control subject while the subjects 
were performing the described tasks. 
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Image processing was performed using the Statistical Parametric Mapping 
(SPM8, update rev. no. 4290, Wellcome Trust Centre for Neuroimaging, Lon-
don, UK) software, which is a suite of MATLAB (The MathWorks, Inc., 
Natick, MA, USA) functions to process and analyse functional neuroimaging 
data (Ashburner et al., 2011). 
The first step of spatial pre-processing was the realignment of functional 
images, where movement effects were discounted. Thereafter high resolution 
anatomical images were co-registered with functional images, to maximize the 
mutual information. Pre-processing continued with segmentation of high 
resolution anatomical images, where the Montreal Neurological Institute (MNI) 
452 white matter, grey matter and cerebrospinal fluid probability maps (Brett et 
al., 2002) were used to yield a parametric description for normalisation. During 
normalisation the images were also bias-corrected. Image pre-processing was 
completed with smoothing by the 8×8×8 mm3 FWHM (full-width at half 
maximum) isotropic Gaussian kernel. 
 
 
4.5. Statistical analysis 
Paper I 
Descriptive data were presented as percentage, mean, median and standard 
deviation. For categorical data, frequencies and percentages were expressed in 
contingency tables and differences were assessed by the Chi-square test. 
Incidence rates with the 95% confidence intervals were calculated using the 
Poisson distribution. The crude incidence rates were calculated using the mid-
year population census for each year and were age- and gender-adjusted to 
Estonian population by direct standardisation (census 2000).  
Trends in incidence were calculated using the Poisson regression model. A 
quasi-Poisson model was used when overdispersion was present. Age (8 cate-
gories) and sex (2 categories) specific incidence rates were calculated over time 
(11 categories).  
The analysis of temporal trends was based on chi-square test for categorical 
data and one-way analysis of variance for continuous data. 
A statistical level of significance of 5% was used (P<0.05), all confidence 
intervals were expressed at 95% (95% CI). 
 
Paper II 
Descriptive data was presented as number, percentage, mean, median and stan-
dard deviation. Differences in categorical data were assessed by the Chi-square 
test. The T-test and analysis of variance were used for continuous variables. The 
incidence rates with 95% confidence intervals were calculated using the Poisson 
distribution. Crude incidence rates of TSCI were calculated for both countries 
using the mid-year population census for each year. Age- and gender-adjusted 
incidences were calculated by the method of direct standardisation, using the 
standard European population structure. We compared mortality by age-groups 
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using the two-sided Fisher exact test and the Kaplan-Meier curves. Cox 
proportional hazards analysis was used to determine the probability of survival 
in the presence of specific risk factors. 
Standardised mortality ratios were calculated as the ratios of the actual 
number of observed deaths to the number of deaths expected in Estonia and 
Norway. However, comparison of indirectly standardised rates is problematic, 
because the reference populations of Norway and Estonia are not the same. In 
order to compare the rates, we calculated SMRs according to EU-15 life tables 
for 2003. Although Estonia belongs to the European Union and Norway does 
not, it is recommended to compare the mortality of each European country to 
the EU-15 average because the EU-27 average would yield a less balanced 
picture (European Communities, 2009). 
A statistical level of significance of 5% was used (P<0.05), all confidence 
intervals (CI) were expressed at 95%. 
 
Paper III 
Standardised mortality ratios (SMRs), survival rates and life expectancy were 
calculated. The SMR is expressed as the ratio of observed deaths of persons 
with TSCI to expected deaths in the general Estonian population. The Kaplan-
Meier curves were used to visualise survival by age at death or to censor the 
SCI population compared to the general population. The cause specific 
mortality rates were based on the underlying cause of death. A Cox proportional 
hazards regression model was used to identify the probability of death in the 
presence of specific risk factors. We used the log-log plot to test the 
proportional hazard assumption that the hazard ratio is constant over time. The 
risk factors were estimated for the patients who lived less than 2 years and for 
those who outlasted the cut-off point of 2 years. This distribution was chosen 
since it has been reported that the risk of death is disproportionately higher 
among patients with high cervical TSCI during the first two years after injury 
(Middleton et al., 2012; Strauss et al., 2000; Strauss et al., 2006). 
The independent variables (age, sex, year of the injury, cause of trauma, pre-
injury alcohol consumption, concomitant injury, head injury, extent of injury, 
vertebral fracture, need for mechanical ventilation, operation in 6 weeks, 
methylprednisolone in acute phase, complications in acute phase), that were 
included in the Cox proportional hazards regression model, were obtained from 
the medical records earlier. Pre-existing conditions or co-morbidities were not 
included into the model because the information gained from the medical 
records was too scarce. 
 
Paper IV 
Image processing was followed by a general linear model-based statistical 
analysis of the functional images. Modelling was done with box car functions 
convolved with canonical hemodynamic response function (HRF). Low 
frequency noise was eliminated by using a 160 s high-pass filter. Estimation of 
the model parameters was done by using SPM8, after which task vs. rest 
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activation was assessed by applying a t-test to the parameter estimates, resulting 
statistical parametric t-maps for each subject. Multiple comparisons’ problems 
were corrected by masking images with the Brodmann area (BA) masks BA 1-
2-3-5 (BA 1, 2, 3 and 5 were analysed as one area), BA 4 and BA 6 from 
MRIcro (Rorden and Brett, 2000) using SPM8 and by applying FWE (family-
wise error) correction with p<0.05 and by discounting all clusters smaller than 3 
voxels. 
From the resulting masked t-maps, the maximum t-test results and the 
Talairach coordinates of the maximum activation were recorded. The total 
volume of all activated cluster(s) in each region of interest (ROI) (defined by 
the masked areas) was calculated and the Talairach coordinates of the geometric 
centre of gravity (COG) of the cluster with a maximum t-test result in each ROI 
were found using MarsBaR release 0.43 (Brett et al., 2002). 
Finally, weighted laterality index (wLI) was calculated using the combined 
bootstrap/histogram analysis approach (Wilke and Schmithorst, 2006). Boot-
strap algorithm helps to evaluate sampling distribution of a sample by re-
peatedly resampling, with replacement, the original sample, which would yield 
approximately the “real” distribution of the original sample. By using the boot-
strap algorithm, 10 000 indices were iteratively calculated with equation (1) at 
different thresholds, where QLH is the sum of all the t-map values in the masked 
area of the left hemisphere and QRH is the corresponding sum for the right 
hemisphere: 
 ܮܫ = ொಽಹିொೃಹொಽಹାொೃಹ   (1) 
 
For each threshold, trimmed mean laterality index was calculated by finding the 
mean value of laterality indices from which 25% of the upper and lower values 
were excluded. Weighted laterality index (wLI) was calculated by equation (2), 
where LI25,i is the trimmed mean laterality index and Wi is the weighting factor 
or threshold where the trimmed mean was calculated as: 
 
 ݓܮܫ = ∑ ௐ೔
೙೔సభ 	×௅ூమఱ,೔
∑ ௐ೔೙೔సభ
  (2) 
 
To avoid statistically unimportant results, limits for a minimum cluster size of 5 
“activated” voxels and a minimal number of 10 “activated” voxels per hemi-
sphere were established.  
Additional statistical analysis was performed using the StatsDirect statistical 
software Version 2.7.8. The t test was used for between-group comparisons 
when the variables followed a normal distribution. When variables did not 
follow a normal distribution, the Mann-Whitney U test was used. Repeated 
measures ANOVA was performed for TSCI between-group comparisons. The 
associations between the volume of activation (VOA) and ASIA motor score or 
time post-injury were estimated using a Pearson correlation. All p-values were 
two-sided. Statistical significance was defined as p<0.05.  
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4.6. Ethics 
All the studies were approved by the Research Ethics Committee of the Univer-
sity of Tartu, Estonia.  
The second study was also approved by the Regional Committee for Medical 
Research Ethics in Norway, the Norwegian Data Inspectorate and the Nor-
wegian Directorate for Health and Social Affairs. 
The study in Paper III received additional approval from the Data Protection 
Inspectorate of Estonia. 
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5.2. Risk factors of TSCI  
The majority of the patients were men (84.5%) (Table 3). The male to female 
ratio was 5.5:1.  
The mean age at injury was 39.0. The proportion of patients older than 60 
years at injury was 15.0%. The youngest TSCI victim was 1 year old and the 
oldest 93 years old. 
 
 
Table 3. Characteristics of traumatic spinal cord injury incident cases in Estonia from 
1997 to 2007. 
 
Characteristics 
Number of cases 595 
Gender   
      Male (%) 503 (84.5%) 
      Female (%) 92 (15.5%) 
Age   
      Mean (s.d.) 39.0 (17.2) 
      Median (range) 36.0 (1.0–92.0) 
Neurological category   
      C1-C4 AIS A, B, C (%) 59 (9.9%) 
      C5-C8 AIS A, B, C (%) 172 (28.9%) 
      T1-S5 AIS A, B, C (%) 159 (26.7%) 
      All AIS D (%) 142 (23.9%) 
      Unknown (%) 63 (10.6%) 
Length of stay in hospital (days)   
      Mean (s.d.) 20.3 (25.1) 
      Median (range) 15 (0–368) 
 
Abbreviation: AIS, American Spinal Injury Association Impairment Scale. 
 
 
Alcohol consumption preceded TSCI in 257 of the cases (43.2%), whereas in 
34.2% of the cases alcohol consumption was unknown or not recorded in the 
medical documents. Significantly more men than women (46.0% vs. 34.7%) 
had signs of alcohol consumption on admission to the hospital (p=0.002). 
Almost half of the patients injured at diving had consumed alcohol (52.7%). 
There was no change in alcohol consumption preceding the trauma from 1997 
to 2007 (p=0.1). 
 
5.3. Causes of TSCI  
The most common cause of TSCI was falls (41.0%), followed by traffic acci-
dents (29.4%) (Figure 3). Falls was significantly more common reason for TSCI 
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in patients aged 30 years accounting for 51.5% of the TSCI cases compared to 
24.4% in those aged <30 years (p<0.001). The highest proportion of falls as a 
cause of TSCI was among patients aged ≥60 years (72.4%). Traffic accidents 
were the most common cause among patients aged <30 years (p<0.001). There 
was no gender difference in the cause. 
Diving was the leading cause of sports injuries (91.4%). Among other in-
juries 31.0% occurred as a result of traumatic blows on tree felling.  
The trauma was work-related in 15.2% of the cases. The main external cause 
was falls (39.1%), followed by accidental tree felling (31.0%). 
 
Figure 4. Number of traumatic spinal cord injury cases by cause in Estonia, 1997–2007. 
 
 
5.4. Severity of TSCI  
The cervical part of the spinal cord was the most common site of injury. The 
injury was sustained at the cervical level in 59.4%, at the thoracic level in 
18.3% and at the lumbar or sacral level in 22.3% of the cases.  Patients aged 
≥60 years had cervical SCI in 80% of cases. Table 3 presents the distribution of 
cases according to recently recommended guidelines (DeVivo et al., 2011). In 
53% of the cases the injury was motor complete (AIS: A and B) and 47% of the 
cases it was motor incomplete (AIS: C and D).  
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5.5. Associated injuries, management and  
complications TSCI  
Spinal column fractures occurred in 76.3% of the cases. Spinal column fractures 
were significantly associated with the severity of injury (p<0.001). The most 
common spine injury occurred at the C5 (17.0%), at the C6 (13.0%) level and at 
the L1 (13.4%) level. In 31.6 % of the cases there occurred  an associated in-
jury, the most frequent being brain injury (30.6%).  
Complications were present in 48.3% of the cases. The most common 
complications detected in the acute phase of TSCI were urinary (46.9%) and 
respiratory tract infections (44.4%) and pressure sores (22.9%). Complications 
were not different between younger patients (<60 years) and the elderly (≥ 60 
years) (p=0.6). The presence of complications was strongly influenced by the 
completeness of injury (more frequent in AIS A, p<0.0001) (Sabre et al., 2012).  
Sixty-five per cent of the patients needed surgical management. Surgical treat-
ment and positive dynamics (AIS grade improvement) were statistically signifi-
cantly related (p=0.005) (data not published). Forty-three per cent of the patients 
received MPSS during the first day after TSCI. Until 2002, 64% of the patients 
were treated with high-dose MPSS, thereafter this figure declined to 20%. 
 
 
5.6. Mortality and causes of death after TSCI 
The analysis was based on 595 patients with TSCI, 162 of whom (139 men and 
24 women) were dead by December 31, 2011. The mean age at the time of 
injury in dead was 50.8 ± 17.7 (range 5–93), 51.0 ± 17.5 years (range 16−93) 
for men and 49.9 ± 19.3 years (range 5−87) for women. Among the patients 
who survived, the mean age at injury was 34.8 ± 14.6 years (range 1−76). 
During the first year after TSCI, there were 46.9% (n=76) deaths. Table 4 
presents the distribution of deaths in different impairment groups.  
 
 
Table 4. Distribution of deaths in patients with traumatic spinal cord injury in Estonia 
from 1997 to 2011. 
 
Impairment 
(neurol. group  
 Injured  Death in  Death in   Death after  
 1997–2007  12 months  2. year  2 years 
and AIS grade)  N  N %  N %  N % 
C1-C4 ABC  59  19 32.2  1 1.7  6 10.2 
C5-C8 ABC  172  35 20.3  4 2.3  23 13.4 
C1-C8 D  96  5 5.2  4 4.2  12 12.5 
Th1-S5 ABC  159  12 7.5  2 1.3  26 16.4 
Th1-S5 D  46  0 0  1 2.2  3 6.5 
Unknown   63  1 1.6  4 6.3  4 6.3 
 
Abbreviation: AIS, American Spinal Injury Impairment Scale. 
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The predominant cause of injury of people who died was falls (41.0%), 
followed by traffic accidents (29.4%).  
During the first year, the leading underlying causes of death were external 
causes of injury (52.6%) and cardiovascular diseases (21.1%). Later, the cardio-
vascular diseases became predominant (35.6%), followed by suicides (13.8%). 
All the patients who committed suicide were male, and all but one attempt 
happened after the first year of TSCI. The survival of the patients whose cause 
of death was suicide was 1951 ± 1342 days. Seven of the patients had tetra-
plegia, 6 had paraplegia.  
The overall SMR was 2.81 (95% CI 2.40−3.28). The SMRs were higher for 
women (Tables 5 and 6). Men with TSCI younger than 76 years and women 
younger than 61 showed increased mortality compared to the general popu-
lation. Figures 5 and 6 illustrate the survival in the study population among men 
and women. 
 
 
Table 5. Standardised mortality ratios (SMRs) for age-groups among males with 
traumatic spinal cord injury in Estonia from 1997 to 2011. 
 
Age-group Observed Expected SMR 95% CI 
0–15 0 0.01 0 0–435.2 
16–30 16 2.7 5.9 3.4–9.7 
31–45 32 6.3 5.1 3.5–7.2 
46–60 43 14.4 3.0 2.2–4.0 
61–75 36 18.7 1.9 1.3–2.7 
>75 12 9.4 1.3 0.7–2.2 
Total 139 51.5 2.7 2.3–3.2 
 
 
Table 6. Standardised mortality ratios (SMRs) for age-groups among females with 
traumatic spinal cord injury in Estonia from 1997 to 2011. 
 
Age-group Observed Expected SMR 95% CI 
0–15 1 0.004 214.2 5.4–1193.6 
16–30 2 0.1 17.4 2.1–63.0 
31–45 8 0.3 23.4 10.1–46.2 
46–60 6 0.6 10.3 3.8–22.3 
61–75 4 1.4 2.8 0.8–7.2 
>75 2 3.6 0.6 0.1–2.0 
Total 23 6.1 3.8 2.4–5.7 
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Figure 5. Survival probability of male with traumatic spinal cord injury (with 95% 
confidence interval), injured from 1997 to 2007, compared with the Estonian 
population.  
Figure 6. Survival probability of female with traumatic spinal cord injury (with 95% 
confidence interval), injured from 1997 to 2007, compared with the Estonian 
population.  
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Table 7. Causes of death of deceased TSCI patients in Estonia from 1997 to 2011.  
 No of deaths 
Causes of death Observed Expected SMR (95% CI) 
Sepsis     
Total 12 0.04 339.5 175.5–593.1 
Male 9 0.03 296.3 135.5–562.4 
Female 3 0.01 604.3 124.6–1765.9 
Cancer     
Total 7 13.9 0.5 0.2–1.0 
Male 5 12.3 0.4 0.1–1.0 
Female 2 1.6 1.2 0.2–1.0 
Cardiovascular disease     
Total 46 30.9 1.5 1.1–2.0 
Male 41 25.7 1.6 1.1–2.2 
Female 5 5.2 1 0.3–2.3 
Respiratory disease     
Total 13 2.4 5.5 2.9–9.4 
Male 11 2.2 2.5 2.5–8.9 
Female 2 0.2 13.1 1.6–47.2 
Digestive system disease     
Total 5 2.6 1.9 0.6–4.4 
Male 5 2.4 2.1 0.7–4.9 
Female 0 0.3 0 0–13.1 
Skin disease     
Total 5 0.05 105.4 34.2–246.0 
Male 5 0.04 128.4 41.6–298.9 
Female 0 0.01 0 0–439.0 
Musculoskeletal disease     
Total 2 0.13 14.6 1.8–52.6 
Male 2 0.1 19.9 2.4–71.8 
Female 0 0.03 0 0–100.8 
Genitourinary disease     
Total 9 0.5 18 8.2 ‒ 34.2 
Male 8 0.42 18.9 8.2 ‒37.2 
Female 1 0.08 13.2 0.3 ‒ 73.7 
External causes of injury     
Total 48 8.4 5.7 4.2–7.6 
Male 38 8 4.7 3.3–6.5 
Female 10 0.4 28.3 13.6–52.1 
Suicide      
Total 13 1.6 8.3 4.4–14.3 
Male 13 1.5 8.7 4.6–14.8 
Female 0 0.05 0 0–65.8 
      
Abbreviations: TSCI, traumatic spinal cord injury; SMR, standardised mortality ratio; 
CI, confidence interval. 
  
 
42 
During the study period, SMR decreased 11% per year from 7.99 to 2.13 
(p<0.001). The mortality rate in the first year of injury did not show any change 
(p=0.29). 
Cause-specific SMR was the highest for sepsis (Table 7). Cause-specific 
SMR for suicide was 8.7 among the men, none of the women committed suicide 
during the study period in Estonia. The sole cause of death with decreased SMR 
compared to the general population was cancer (Table 7). 
Cox proportional hazards modelling revealed several predictors of mortality 
(Table 8). During the first two years, the significant risk factors of death were 
higher age at injury, cervical spinal cord injury, completeness of injury and 
concomitant trauma, including head injury.  During the first post-injury year, 
the patients with C1-4 (AIS A-C) neurological impairment had 6.25 times 
higher risk of dying compared with the patients with injury below the cervical 
level. They had also 7 times higher risk of dying than those with C1-8 AIS D 
impairment (Table 4). After the first year, the risks levelled off. Figure 7 
illustrates survival probability in the study population for different levels of 
neurological impairment. Two years after the injury only age and completeness 
of lesion remained significant risk factors for death, the cause of injury also 
became significant.  
 
Figure 7. Survival probability of patients with traumatic spinal cord injury with 
different level and extent of neurological impairment, injured from 1997 to 2007 in 
Estonia. 
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Table 8. Risk factors for death of patients with TSCI in Estonia from 1997 to 2011. 
 
Factors  <2 years after TSCI  >2 years after TSCI 
  RR 95% CI p-value  RR 95% CI p-value 
Age at injury  1.05 1.04–1.06 <0.001  1.04 1.03–1.05 <0.001 
Gender         
Male  1.00 – –  1.00 – – 
Female  0.96 0.54–1.74 0.91  0.84 0.44–1.67 0.65 
Year  0.97 0.91–1.03 0.29  0.92 0.85–1.00 0.06 
Cause of trauma         
Sport (ref.)  1.00 – –  1.00 – – 
Assault  1.35 0.45–4.04 0.59  1.04 0.20–5.36 0.96 
Traffic accident  1.02 0.46–2.23 0.97  1.52 0.56–4.15 0.41 
Falls  1.70 0.83–3.48 0.14  3.90 1.56–9.83 0.004 
Other  1.24 0.48–3.21 0.66  0.79 0.19–3.32 0.75 
Preinjury alcohol consumption     
No (ref.)  1.00 – –  1.00 – – 
Yes  1.29 0.75–2.24 0.40  1.39 0.76–2.54 0.29 
Concomitant injury         
No (ref.)  1.00 – –  1.00 – – 
Yes  1.34 0.87–2.06 0.18  0.93 0.55–1.58 0.80 
Head injury         
No (ref.)  1.00 – –  1.00 – – 
Yes  1.84 1.20–2.83 0.005  0.96 0.57–1.61 0.87 
Neurological level         
C1‒4  5.00 2.64–9.48 <0.001  1.19 0.54–2.59 0.67 
C5‒8  2.88 1.64–5.06 <0.001  0.98 0.60–1.60 0.93 
T1‒S5  1.00 – –  1.00 – – 
Completeness of injury     
Complete (ref.)  1.00 – –  1.00 – – 
Incomplete  0.29 0.19–0.45 <0.001  0.80 0.50–1.30 0.37 
Vertebral fracture         
No (ref.)  1.00 – –  1.00 – – 
Yes  0.75 0.48–1.87 0.23  0.67 0.42–1.09 0.12 
Mechanical ventilationa    
No (ref.)  1.00* – –  1.00 – – 
Yes  * * 0  0.89 0.39–2.06 0.78 
Operation in 6 weeks         
No (ref.)  1.00 – –  1.00 – – 
Yes  0.30 0.19–0.47 <0.001  0.80 0.51–1.25 0.33 
Methylprednisolone in acute phaseb  
No (ref.)  1.00 – –  1.00 – – 
Yes  1.26 0.80–1.98 0.32  0.97 0.60–1.59 0.92 
Complication in acute phaseb     
No (ref.)  1.00 – –  1.00 – – 
Yes  2.00 1.25–3.16 0.004  1.48 0.93–2.35 0.1 
 
Abbreviations: TSCI, traumatic spinal cord injury; RR, relative risk; CI, confidence 
interval. 
* Assumptions for the proportional hazards analysis were not fulfilled 
a – use of ventilation assistance during hospital stay in the acute phase of injury 
b – acute phase is defined as the first hospitalisation after the injury 
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5.7. Comparison of TSCI between  
Estonia and Western Norway  
A total of 71 patients were identified in Western Norway and 244 patients in 
Estonia during the study period from 1997 to 2001. The male to female ratio 
was higher in Estonia 6.0:1 than in Western Norway 3.4:1. The mean age at the 
time of injury was 10 years higher in Norway (p<0.001) (Table 9). 
The annual crude incidence rate was 26.3 (95% CI 20.5−33.1) in Norway 
and 35.4 (95% CI 31.1−40.1) in Estonia. After standardisation to the standard 
European population the annual age- and gender adjusted incidence rates were 
24.9 (95% CI 19.4−31.7) in Norway and 37.4 (95% CI 32.8−42.5) in Estonia. 
Figure 8 shows the age- and gender-specific incidence rates in the two 
countries.  
The leading cause of TSCI was falls in both countries, followed by MVA 
(Table 9).  
 
 
 
Figure 8. Age- and gender-specific incidences in Western Norway and Estonia in the 
period 1997 to 2001. 
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Table 9. Characteristics of traumatic spinal cord injury in Western Norway and Estonia 
from 1997 to 2001. 
 Overall cases  Deceased cases 
Characteristics 
Western 
Norway Estonia  
Western 
Norway Estonia 
Number of cases 71 244  26 86 
Gender      
      Male (%) 55 (77.5) 209 (85.7)  20 (76.9) 74 (86.1) 
Age      
      Mean (s.d.) 48.9 (23.0) 38.9 (17.3)  65.0 (19.2) 47.4 (17.8) 
      Median (range) 51.0 (8−90) 36.0 (5−93)  72.5 (22−90) 47.5 (5−93) 
Cause of injury (%)      
Fall 32 (45.1) 89 (36.5)  14 (53.9) 39 (45.4) 
Motor vehicle accident 29 (40.8) 74 (30.3)  9 (34.6) 26 (30.2) 
Sport 7 (  9.9) 34 (13.9)  2 (  7.7) 10 (11.6) 
Other 3 (  4.2) 47 (19.3)  1 (  3.9) 11 (12.8) 
Level of injury (%)      
Cervical 41 (57.8) 141 (57.8)  21 (80.8) 59 (68.6) 
Thoracic 15 (21.1) 44 (18.0)  3 (11.5) 15 (17.4) 
Lumbar 15 (21.1) 48 (19.7)  2 (  7.7) 10 (11.6) 
Unknown 0 (0.0) 11 (4.5)  0 (0.0) 2 (2.3) 
Severity of injury (%)      
Complete 22 (31.0) 99 (42.3)  8 (30.8) 44 (51.2) 
Incomplete 49 (69.0) 135 (57.7)  18 (69.2) 40 (46.5) 
Unknown 0 (0.0) 0 (0.0)  0 (0.0) 2 (2.3) 
Neurological level      
Tetraplegia 30 (42.3) 115 (47.1)  21 (80.8) 51 (59.3) 
Paraplegia 41(57.7) 116 (47.5)  5 (19.2) 33 (38.4) 
Unknown 0 (0.0) 13 (  5.3)  0 (0.0) 2 (2.3) 
Traumatic brain injury     
Mild 23 (32.4) 60 (24.6)  8 (30.8) 25 (29.1) 
Moderate/ hard 12 (16.9) 26 (10.7)  5 (19.2) 13 (15.1) 
No 36 (50.7) 141 (57.8)  13 (50.0) 43 (50.0) 
Unknown 0 (0.0) 17 (  7.0)  0 (0.0) 5 (5.8) 
Alcohol      
Yes 15 (21.1) 86 (35.2)  5 (19.2) 35 (40.7) 
No 18 (25.4) 61 (25.0)  4 (15.4) 17 (19.8) 
Unknown 38 (53.5) 97 (39.8)  17 (65.4) 34 (39.5) 
 
Abbreviation: s.d.: standard deviation. 
 
 
Examining the causes of trauma in different age-groups, it appeared that falls 
was the main cause among the elderly patients in both countries. The mean age 
for patients having to sustain a TSCI due to falls was much higher in Norway 
(p<0.001). There were more MVA among people aged <60 years in Norway 
(p=0.005), but the mean age at MVA was rather similar in both countries. 
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There was a statistically significantly higher proportion of cervical injuries 
among the patients aged ≥60 years than among the younger patients (p=0.03) in 
Western Norway, while cervical injuries was predominating in both age groups 
in Estonia. The majority of the elderly presented with tetraplegia in both 
countries (68% in Estonia, 89% in Norway).  
Analysis showed that a higher percentage of the patients had consumed 
alcohol prior to the accident in Estonia (35% in Estonia and 21% in Western 
Norway, p=0.03). However, as in more than half of the cases in both countries 
alcohol consumption remained unknown, the percentages may be unde-
restimated.  
By the end of the follow-up, 35.3% of the patients in Estonia and 36.6% in 
Western Norway were dead. Mortality was high among the TSCI patients in 
both countries (Table 10).  
 
 
Table 10. Standardised mortality ratios (SMRs) for age-groups in Western Norway and 
Estonia from 1997 to 2011 (EU-15 as the reference population). 
 
 Western Norway Estonia 
Age-
group 
Ob-
served 
Ex-
pected SMR 95% CI 
Ob-
served
Ex-
pected SMR 95% CI 
0–29 1 0.09 10.53 0.27–58.67 13 0.37 35.45 18.88−60.62 
30−59 4 0.82 4.88 1.33–12.48 48 3.94 12.18 8.98−16.15 
60+ 21 10.34 2.03 1.26–3.10 25 16.01 1.56 1.01−2.30 
Total 26 13.77 1.89 1.23–2.77 86 17.21 5.00 4.00−6.17 
 
Abbreviation: CI: confidence interval. 
 
 
The median survival time among the deceased was 4.0 (95% CI 1.50−6.50) 
years in Norway and 2.79 (95% CI 1.54−4.04) in Estonia. Although the overall 
mortality was similar in the two countries, the Kaplan-Meier curves confirmed 
the large discrepancies (Figure 9). Higher percentage of young victims died 
during the follow-up period in Estonia. The survival of people older than 60 
years was similar in two countries.  
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Figure 9. Survival of persons with traumatic spinal cord injury in three age-groups in 
Western Norway and Estonia from 1997 to 2011. 
 
 
The SMR was significantly higher among the women compared to the men in 
Estonia (3.55 vs. 2.85), with an overall SMR of 4.00. In Norway the numbers 
were more similar: SMR 2.35 (1.98 for women, 2.14 for men). As reported in 
Methods, in order to compare the SMRs we used EU-15 as the reference 
population. The SMR values were 2.65 times higher in Estonia (Table 10). 
Analysis of SMR in different age-groups revealed that the ratio for the two 
countries was 3.4 times higher in Estonia among the patients aged 0−29 years, 
2.5 times higher among the 30–59-year-old victims and slightly lower (RR= 
0.77) among the patients 60 years or older compared to Norway.  
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When using Cox regression analysis, age and neurological and anatomical 
levels of injury were significant risk factors for mortality in Western Norway. In 
Estonia age, severity and neurological and anatomical levels of injury, as well 
as concomitant brain injury and alcohol consumption were significant risk 
factors for mortality within 15 years of TSCI (Table 11).   
 
 
Table 11. Cox regression model for risk indicators for death in Western Norway and 
Estonia. 
 
 Western Norway Estonia 
Potential risk factors 
Hazard 
ratio 95 % CI p-value  
Hazard 
ratio 95 % CI p-value 
Age at injury, years 1.05 1.03−1.07 <0.001  1.03 1.02−1.05 <0.001 
Gender       
    Male 0.94 0.38−2.34 0.89 1.00 0.55−1.85 0.99 
    Female 1.00 ref  1.00 ref  
Aetiology of injury   0.81   0.71 
Fall 1.20 0.16−9.15  2.11 1.08−4.13  
MVA 0.73 0.09−5.75  1.62 0.80−3.29  
Sport 0.71 0.06−7.82  1.35 0.57−3.17  
Other 1.00 ref  1.00 ref  
Neurological level       
Tetraplegia 3.72 1.40−9.87 0.003 1.84 1.17−2.89 0.008 
Paraplegia 1.00 ref  1.00 ref  
Completeness       
Completeness 0.97 0.42−2.22 0.94 1.83 1.18−2.84 0.007 
Incomplete 1.00 ref  1.00 ref  
Anatomical level       
    Cervical injury 3.72 1.40−9.87 0.003 1.74 1.07−2.82 0.02 
    
Thoracic/lumbosacra
l injury 1.00 ref  1.00 ref  
Traumatic brain injury     
    Yes 1.03 0.48−2.22 0.94 1.70 1.10−2.63 0.02 
    No/ unknown 1.00 ref  1.00 ref  
Alcohol consumption       
    Yes 0.84 0.32−2.23 0.72 1.27 0.81−1.98 0.30 
    No/ unknown 1.00 ref    1.00 ref   
 
Abbreviation: CI: confidence interval. 
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Activation patterns of the control subjects 
The mean movement rate of the control subjects was 0.58 ± 0.17 Hz during 
hand movement and 0.46 ± 0.13 Hz during ankle movement (in patients with 
complete TSCI, the rate was 0). There was no significant correlation between 
movement rate and volume of BA 4 activation in the control group. In the 
control subjects studied twice (7 individuals), no significant change of VOA in 
BA 4 (hand p=0.56, ankle p=0.18), BA 1-2-3-5 (hand p=0.45, ankle p=0.42) or 
BA 6 area (hand p=0.48, ankle p=0.99) was found. The location of BA 4 
activation was in the left anatomical hand region for all but one subject, who 
had no activation in this region at the chosen threshold. The COG coordinates 
did not change significantly during one year (Table 13).  
 
 
Table 13. Volumes of activation, maximum t-values, centres of gravity and weighted 
laterality indexes of the right hand and ankle movement representation in the controls 
during 1 year in fMRI study. 
  Hand Study 1 Study 2  Ankle Study 1 Study 2 
FWE corrected   0.05 0.05   0.05 0.05 
BA 1-2-3-5         
No. of subjects 
with activation   6 6   3 3 
VOA ± s.d. (mm3)   3748 ± 4657 1536 ± 909   172 ± 33 169 ± 34 
Maximum t-value   8.7 ± 1.7 8.5 ± 1.0   6.6 ± 0.6 6.6 ± 1.2 
COG x   –42.9 ± 3.4 –41.6 ± 5.8   –10.3 ± 7.7 –5.7 ± 0.6 
COG y   –26.9 ± 3.6 –25.9 ± 4.8   –37.9 ± 0.8 –39.2 ± 1.2 
COG z   54.6 ± 4.1 52.8 ± 4.5   66.1 ± 3.4 64.0 ± 1.6 
wLI   0.79 ± 0.15 0.68 ± 0.16   0.17 ± 0.52 0.12 ± 0.36 
BA 4         
No. of subjects 
with activation   6 6   6 5 
VOA ± s.d. (mm3)   2579 ± 974 2142 ± 610   1823 ± 1131 2073 ± 1174 
Maximum t-value   9.8 ± 1.2 9.8 ± 1.2   8.5 ± 1.2 8.4 ± 2.3 
COG x   –39.0 ± 1.7 –39.3 ± 2.7   –5.5 ± 1.6 –6.1 ± 1.4 
COG y   –21.3 ± 1.8 –20.9 ± 2.4   –27.2 ± 2.1 –26.0 ± 1.4 
COG z   57.3 ± 2.0 57.1 ± 2.3   66.2 ± 1.5 67.3 ± 1.5 
wLI   0.94 ± 0.04 0.88 ± 0.18   0.65 ± 0.17 0.73 ± 0.14 
BA 6         
No. of subjects 
with activation   6 6   6 5 
VOA ± s.d. (mm3)   4728 ± 3148 2743 ± 1195   1869 ± 1300 1794 ± 707 
Maximum t-value   11.2 ± 1.4 9.4 ± 1.1   7.6 ± 1.4 8.4 ± 2.3 
COG x   –32.7 ± 4.1 –34.5 ± 4.1   –3.4 ± 3.0 –7.8 ± 6.9 
COG y   –13.6 ± 1.8 –14.8 ± 11.7   –9.6 ± 4.2 –12.2 ± 2.9 
COG z   62.4 ± 3.2 62.3 ± 3.4   69.1 ± 2.9 69.2 ± 2.4 
wLI   0.79 ± 0.14 0.69 ± 0.15   0.27 ± 0.13 0.46 ± 0.22 
 
Abbreviations: FWE, corrected for family-wise error; BA, Brodmann area; VOA, 
volume of activation; s.d., standard deviation; COG, centre of gravity; wLI, weighted 
laterality index. 
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Activation patterns of the TSCI patients 
The mean hand movement rate was lower in the TSCI patients’ group compared 
to the controls (0.36 ± 0.19 Hz, p=0.02). A significant relationship was found 
between movement rate and the ASIA motor score (r=0.53, p=0.001). There 
were also significant correlations between the VOA in BA4 and ASIA motor 
score. The correlation was the highest immediately after injury (r=0.82, 
p=0.002), veering towards no correlation by 3 months later (r=0.63, p=0.03) and 
12 months later (r=0.23, p=0.52). 
Among the patients who recovered, the VOA in BA 4, BA 6 and BA 1-2-3-5 
was increased compared to those whose neurological state did not change 
during the year. This phenomenon was found in hand as well as in ankle move-
ment.  
The overall VOA in the primary motor cortex of the patients who recovered 
was higher compared with that of other patients (hand p=0.06, ankle p=0.02). 
Due to the huge variability of VOA in BA 1-2-3-5 and BA 6 the difference did 
not reach a statistically significant level (BA 1-2-3-5: hand p=0.08, ankle p=0.1; 
BA 6: hand p=0.05, ankle p=0.04).  
At the first, second and third study sessions, a specific pattern of activation 
was found. The activation area was enlarged at the beginning of the study (first 
three months) and reached the level of the controls and the patients who did not 
recover by the end of the first year.  
The overall location of COG in BA 1-2-3-5, BA 4 and BA 6 was similar 
among the patients who did not recover and the controls. There was no shift in 
COGs during the first year post-TSCI. During the hand task from the first to the 
third study session there was an expansion of COG laterally, anteriorly and 
inferiorly among the patients who recovered (BA 4: x –35.5 to –46.9, p=0.13; y 
–22.5 to –14.0, p=0.15, z 57.4 to 48.8, p=0.21; BA 1-2-3-5: x –38.2 to –47.2, 
p=0.14; y –28.9 to –27.1, p=0.14; z 54.5 to 47.8, p=0.23). Among the TSCI 
patients who recovered, the shift of COG during ankle movement was medial, 
anterior and superior in BA 4 (x: –6.3 to –1.8, p=0.02; y: –25.7 to –23.2, p= 
0.16; z 63.8 to 66.0, p=0.25).  
Brain activation was more bilateral in the TSCI patients than in the controls 
(Table 14). In BA 4 the mean wLI was 0.72 ± 0.19 during right hand movement 
among the patients compared to 0.90 ± 0.11 among the controls (p<0.001). 
Similarly, in BA 6 and BA 1-2-3-5 wLI was less lateralised during hand 
movement among the patients (0.59 ± 0.29 vs 0.74 ± 0.16, p=0.005; 0.50 ± 0.29 
vs 0.73 ± 0.14, p=0.02). During leg movement the differences in wLI  between 
the patients and the controls did not become statistically significant (BA 4 
p=0.22; BA 1-2-3-5 p=0.95; BA 6 p=0.37). 
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6. DISCUSSION 
TSCI constitutes a major source of the socio-economic burden to society 
(Ackery et al., 2004). As the costs of acute care, inpatient rehabilitation and 
postdischarge community therapeutic interventions are rising, there is a strong 
need to determine the situation in a concrete country (Ackery et al., 2004; Chiu 
et al., 2010; Wyndaele and Wyndaele, 2006).  
 
 
6.1. Incidence of TSCI in Estonia 
The reason why the current study was undertaken is that there is a paucity of 
studies of TSCI in Eastern Europe and Estonia (Figure 15). Relevant data reflect 
the level of controlling SCI and point to the need for improving preventable 
strategies. Neither reduction in the number or severity of TSCI or mortality after 
TSCI, nor improvements in the care of SCI will be possible if there is no 
reliable information about the epidemiological scale of SCI. 
Paper I shows the high incidence of spinal cord injuries in Estonia. Previous 
international studies have been mostly hospital based (van Asbeck et al., 2000; 
Berg et al., 2011) or limited to adult population (Ahoniemi et al., 2008). To our 
knowledge, the present study is the first population-based research that included 
all age groups from all hospitals across the whole country.  
The incidence of TSCI differs greatly between countries. The crude in-
cidence of TSCI was 39.7 per million in Estonia from 1997 to 2007, which is 
one of the highest in Europe. Only a Portugal study, which included prehospital 
mortalities reported higher incidence rate (Martins et al., 1998).  
On the other hand, lack of standardised global reporting of aetiology data on 
TSCI reduces the ability of the data to contribute to specific injury prevention 
strategies or hypotheses worldwide (Cripps et al., 2011). Until now, only one 
study group has conducted a comparative research on TSCI in two different 
countries at the same time (Divanoglou and Levi, 2009). In the second paper we 
compared the incidence, characteristics and mortality of TSCI in Western 
Norway and Estonia. Previous population studies have revealed several 
differences in the lifestyle in the Baltic countries compared to Western Europe, 
differences that may negatively influence the health status and the risk of 
trauma (Rekand et al., 2004).  
The standardised annual age- and gender adjusted incidence rates were 24.9 
and 37.4 in Norway and Estonia, respectively, i.e. 1.5 times higher in Estonia 
than in Western Norway.   
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Figure 15. Incidence of TSCI in Europe, per million population. 
(Ahoniemi et al., 2008; Albert et al., 2009; Biering-Sorensen et al., 1990; Divanoglou et 
al., 2009; Exner et al., 1997; Hagen et al., 2010a; Kondakov et al., 2002; Knútsdóttir et 
al., 2012; Martins et al., 1998; O’Connor et al., 2006;  Pagliacci et al., 2003; 1998; 
Soopramanien, 1994; van Asbeck et al., 2000; van den Berg et al., 2010b) 
 
 
The first reason for the difference is due to socioeconomic circumstances. Poor-
ly managed societal transition to market economy, higher unemployment, in-
equalities in wealth, poor regulatory and enforcement mechanisms predispose 
Eastern Europe and Eurasian countries to high personal burden of injuries 
(Hyder and Aggarwal, 2009). It has been found that people in low-to-middle 
outcome countries are 3.6 times more likely to die from injuries (Sethi et al., 
2006).  
The second explanation is closely related to preventive measures. There has 
been an extensive focus on prevention of traumas in Norway while less effort 
has been directed to prevention in Estonia. Campaigns targeting young drivers 
have reduced the number of injuries among younger people (Lai et al., 2005) 
The third explanation is geographical differences. The risk of traumatic 
spinal cord injury was 2.5 times higher in rural than in urban areas of Canada 
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(Dryden et al., 2003). Western Norway is dominated by mountains and fjords, 
which reduces speeding options. On the other hand, falling from height could be 
more frequent in these regions. The landscape of Estonia is flatter, allowing 
motor vehicles to drive at a high speed.  
In the first study we found an increasing trend in the incidence from 1999 to 
2007 in Estonia. The possible explanation is that the prevention of TSCI was 
ineffective. Another explanation may be that we missed some cases in the first 
study years. However, the incidence rates were fluctuating at the beginning of 
that period (Figure 4). In this connection it should be noted that Hagen and 
colleagues have reported an increasing trend in the TSCI incidence rates when 
the study period was longer (Hagen et al., 2010a). Still, no clear explanation has 
been given yet for this phenomenon. 
The strength of the studies in Papers 1 and 2 was the inclusion of the whole 
Estonian population in the study. Also, several overlapping sources of informa-
tion were reviewed to minimize errors and missing cases. Medical records were 
reviewed even in the smallest local hospitals where patients with TSCI are 
usually not treated. Thus, we probably missed no cases.  
The studies had some limitations. Firstly, we did not include the patients 
who died before the arrival to hospital. Only three studies by other authors have 
included fatal cases before hospitalisation so far and have presented higher 
incidence rates than other studies (Wyndaele and Wyndaele, 2006). A study of 
prehospital mortality is currently in progress in Estonia. Secondly, we identified 
the TSCI patients by the diagnostic codes only. However, the list of the ICD-10 
codes suggesting a TSCI was expanded to cover spinal fractures at every level 
in order to obtain more cases. Thirdly, as the study was performed with a retro-
spective design available information was probably limited. In order to show 
trends in TSCI, a prospective register providing full coverage of the population 
would be needed. 
 
 
6.2. Risk factors of TSCI 
Consistent with previous studies (Ackery et al., 2004; Ahoniemi et al., 2008; 
Albert et al., 2005;  Berg et al., 2011; Biering-Sørensen et al., 1990; Celani et 
al., 2001; Chiu et al., 2010; Dincer et al., 1992; Divangolou and Levi, 2009; 
Dryden et al., 2003;  Espagnaq et al., 2011; Exner and Meinecke, 2010; Hagen 
et al., 2010a; Jackson et al., 2004; Karacan et al., 2010;  Kondakov et al., 2002; 
Knútsdóttir et al., 2012; Martins et al., 1998; O’Connor, 2002; O’Connor and 
Murray, 2006;  Pagliacci et al., 2003; Pickett et al., 2006; Soopramanien, 1994; 
Surkin et al., 2000; van Asbeck et al., 2000; van den Berg et al., 2010b; Wyn-
daele and Wyndaele, 2006), men were more prone to TSCI in all age-groups in 
Estonia. There is no clear explanation why men are at greater risk for TSCI. It 
has been suggested that women perform risky activities more cautiously than 
men and therefore may be exposed to lower risk of injury. An international 
comparative study from 19 European countries found that women drive safer 
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than men (Golias et al., 2002). This study also showed that men below the age 
of 55 have the most dangerous driving behavior. 
Many developed countries have reported the bimodal distribution of TSCI 
incidence rates with the second peak after the age of 60 (Berg et al., 2011; 
Dryden et al., 2003). This has been explained by the fact that the mean age at 
the time of injury is increasing because population is aging. The percentage of 
people older than 65 years is even higher in Estonia than the European region 
average (European Union, 2010). However, our data did not reveal this bimodal 
distribution. The incidence was very high in the age-group of 20-29 years in 
Estonia and declined substantially with increasing age becoming similar to that 
in other European countries. 
In comparing Estonia and Western Norway in the Paper 2, the general 
population aged 60 years or more is high in both regions. Still, the proportions 
of TSCI patients in Estonia and in Western Norway are poles apart – young 
men in Estonia and elderly men in Norway. There is no convincing explanation 
for that. We may postulate that the elderly in Estonia might be less healthy, 
functionally less capable and do not take part in potentially dangerous activities. 
The latter hypothesis is based on the finding that physical activity is associated 
with increased longevity (Gulavik et al., 2012). Studies have found people in 
the Baltic countries to be physically inactive (Pomerleau et al., 2000). For 
example a study on the lifestyle and sequels of poliomyelitis found that physical 
activity is lower in Estonia compared with Norway (Rekand et al., 2004). How-
ever, intrinsic and also extrinsic risk factors should be taken into consideration. 
Alcohol consumption is high in Estonia and alcohol abuse before TSCI was 
recorded in almost half of the cases in Estonia. Higher percentage of patients 
had consumed alcohol prior to accident in Estonia compared with Western 
Norway. Since 2005 the government alcohol policy has become more strict in 
Estonia and alcohol consumption has decreased since 2008 (Lai and Habicht, 
2011). Our study included the cases until 31 December, 2007 and it found no 
statistically significant decrease in alcohol consumption preceding trauma. 
Alcohol abuse is a clear risk factor for TSCI. There is a need for more effective 
preventive measures concerning alcohol.  
 
 
6.3. Causes of TSCI 
In Europe traffic accidents cause 23 to 72% of all TSCI, with the highest 
percentage in Central Europe (Cripps et al., 2011; Divangolou and Levi, 2009; 
Soopramanien, 1994). The percentages of TSCI due to falls vary between 17 to 
49% (Catz et al., 2002; Cripps et al., 2011; van Asbeck et al., 2000). In line 
with previous studies (Ahoniemi et al., 2008; Hagen et al., 2005; Silberstein 
and Rabinovich, 1995), falls is the most frequent cause of TSCI in Estonia as 
well as in Western Norway. 
Persons between 20 and 29 years of age are most often injured in traffic 
accidents and diving. We also found that most of the sport injuries in Estonia 
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were caused by diving. Consistent with a previous report (European Union, 
2010), young healthy men in their early twenties are usually the victims of 
diving accidents. In Estonia falls became the most prevalent cause of TSCI 
among persons older than 29 years. 
U-shaped association has been found between physical activity and the risk 
of falling (Chan et al, 2007; Gregg et al., 1998). Although a less active lifestyle 
is a risk factor for falling, the highly active lifestyle in patients with balance 
problems as well as coexisting medical problems may predispose the Nor-
wegian elderly to falls.  
Falls was also the most prevalent external cause of TSCI occurring in the 
workplace, followed by blows to the vertebral spine. It shows that Estonian 
workers as well as employers should be better educated regarding safety.  
Taking into consideration that TSCI incapacitates a higher proportion of 
inhabitants in Estonia than in other European countries, preventive measures 
should be more efficacious in general. The measures should be specifically 
targeted to the younger age-groups, particularly men.  
 
 
6.4. Mortality and causes of death after TSCI 
Our study is the first research to examine mortality after TSCI in Eastern 
Europe. As expected, the life expectancy of patients with TSCI was found to be 
significantly reduced in comparison to the general population. Almost half of 
the patients died during the first year after TSCI. The risk of death was higher in 
the group with C1-4 AIS A-C lesions. The rate of SMRs is higher among 
women and the cause-specific SMRs in Estonia were noted to be extremely 
high for sepsis and skin-related causes, as well as also significantly increased 
for other causes including genitourinary disease and suicide. In fact, there is a 
large discrepancy in life expectancy rates between different survival studies, 
which can be attributed to some methodological differences. Most of them have 
excluded patients who die at the scene of the accident, on arrival at the hospital, 
or during the first days. Many studies have focused on patients in the rehabili-
tative phase and have excluded deaths occurring in the acute or sub-acute phase 
of injury (van den Berg et al., 2010; Soden et al., 2000). Therefore, the 
mortality rates are considerably variable.  
Our results have a number of similarities with the findings of Hagen et al.’s, 
showing that women and patients younger than 40 years of age at the time of 
injury have particularly decreased life expectancy (Hagen et al., 2010b). It is 
noteworthy that so far only Scandinavian countries have reported higher female 
mortality (Ahoniemi et al., 2011; Hagen et al., 2010b; Hartkopp et al., 1997; 
Lidal et al., 2007). However, in our study, gender was not statistically signi-
ficant in the Cox proportional hazard modelling. This could be explained by the 
fact that mortality among men in the general population in Estonia is high, 
which diminishes differences between the sexes (European Communities, 
2009).  
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Physical changes after TSCI affect the patient emotionally, socially and 
psychologically. Krause et al. have pointed out that important predictors of 
mortality are social support, income, psychology and behavioural factors 
(Krause et al., 2009; Krause et al., 2011). It is worthwhile noting the results 
from Pentland et al. claiming that women with TSCI feel themselves in iso-
lation and have the perception of being forgotten (Pentland et al., 2002). Factors 
such as these may have an impact on the observed high risk of death in women.  
Consistent with earlier studies, the incidence of death in patients with TSCI 
from septicaemia, respiratory diseases, diseases of urinary system and suicide is 
significantly higher than in general population (Hagen et al., 2010b; Soden et 
al., 2000). Soden et al. suggest that TSCI places patients at a considerable risk 
of suicide (Soden et al., 2000). Suicide generally is also a major issue in Estonia 
(Värnik, 2012). After the first year, the incidence of suicides increased to 13.8% 
among patients with TSCI in Estonia. In contrast to a Finnish study (Ahoniemi 
et al., 2011), the patients who committed suicide in Estonia were men, and half 
of them had tetraplegia.  
Survival is considered to be strongly related to neurological level and degree 
of impairment (DeVivo et al., 1999; Middleton et al., 2012; van den Berg et al., 
2010). Although in recent years there has been a trend towards improvement in 
acute phase survival rates, longer term mortality has remained constant 
(DeVivo, 2007). As might have been expected, we also found a strong relation-
ship between neurological level and completeness of injury. During the first 
year, the mortality risk was significantly higher among the patients with C1-4 
injury level, AIS A, B, C, which stabilised thereafter. No significant reduction 
in the first-year mortality was detected during the follow-up period from 1997 
to 2011 in Estonia. This is hard to explain, because progressive economical 
development and improvements in medical care were taking place in Estonia 
during the period predicting decline in mortality.  
Surprisingly, alcohol consumption before the trauma did not have an effect 
on early or late mortality in our research. It is plausible that data about regular 
alcohol drinking, not available in our study, could have influenced the obtained 
results. Alcohol-attributable mortality is more than 4 times higher for men and 
more than 3 times higher for women in the Baltic countries (Rehm et al., 2011). 
Krause et al. showed that alcohol drinking, especially binge-drinking, is a type 
of behaviour related to early mortality (Krause et al., 2009). According to this 
risk factor, and the findings that Estonians engage in binge drinking (McKee 
and Britton, 1998), we would suggest that alcohol drinking be considered as an 
important risk factor in Estonia for mortality after TSCI.  
Limitations of the mortality study include insufficient information on the 
patients’ death certificates regarding the causes of death. This has also been a 
noted problem in other studies (Middleton et al., 2012). Some SMRs have been 
calculated on the basis of few deaths and should therefore be interpreted with 
caution. The risk factors were collected during the first hospitalisation and were 
not assessed later. Chronic diseases as a potential risk factor for death were not 
included in the analysis because the data were too scarce. Our study was 
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retrospective and identification of patients took place according to the diag-
nostic codes. Patients who died before arrival at the hospital were excluded, 
which may have induced underestimation of the mortality rates.  
Despite the above-mentioned limitations, it is a unique study focused on all 
age-groups in the Estonian population. Patients with TSCI were sought retro-
spectively from every Estonian hospital, and the list of ICD-10 codes 
suggesting a TSCI was expanded to include spinal fractures at every level in 
order to gain more cases (Table 1). The overall SMR confirm that mortality is 
high among patients with TSCI in Estonia. In the current study we identified 
that age at the time of injury, C1-C4 neurological level and completeness of 
injury, as well as concomitant injuries, are the risk factors for death during the 
first two years after the injury. Later, only age, completeness of trauma and 
cause of TCSI are significant risk factors for mortality.  
In conclusion, the main causes of death among patients with TSCI are 
cardiovascular diseases, pneumonias, genitourinary tract infections and in-
fections related to pressure areas, and suicide. The overall life expectancy of the 
patients is significantly decreased compared with general population. The 
assertion by Hitzig et al. that TSCI represents a model of premature aging 
(Hitzig et al., 2011) affecting multiple body structures and functions, should 
lead us to a holistic focus on multi-system management addressing all 
modifiable risk factors and their potential interactions.  
 
 
6.5. Prediction of recovery after TSCI 
Our study provides considerable insight into the changes of brain activation 
after TSCI. We found that the brain activation patterns for patients who have 
recovered and for those who have not recovered are significantly different 
during the first three months after the injury. Activation is increased among the 
patients who recover. To our knowledge, our study is the first to identify a shift 
in activation during the acute phase of cervical TSCI. We suggest that the 
results offer unique evidence for the usefulness of fMRI as a surrogate marker 
for outcome after TSCI.  
One of the main goals of the study was to find brain activation pattern 
changes in patients with cervical TSCI. Until now, only two studies have been 
performed to report the temporal evolution of cortical sensorimotor activity 
after TSCI (Jurkiewicz et al., 2007; Jurkiewicz et al., 2010). In their first study, 
where TSCI patients with motor recovery were studied, a progressive en-
largement in the primary motor cortex and decreased activation in associated 
cortical areas was detected (Jurkiewicz et al., 2007). When they studied 4 
tetraplegic individuals whose paralysis persisted, the activation was extensive in 
associated areas in the early post-injury period but progressed toward no 
activation by the end of the first year (Jurkiewicz et al., 2010). Our results differ 
slightly from the earlier findings. Soon after the injury the activation was 
enlarged only among those TSCI patients who recovered and the enlargement 
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was detected in every ROI we investigated. However, the activation decreased 
by the end of the first year and became similar among the patients and the 
controls.  
Despite the fact that 2 types of spatial shift have been observed, medial and 
posterior, we detected a shift of COG in BA 4 and BA 1-2-3-5 laterally, 
anteriorly and inferiorly during right hand movement. Earlier studies that have 
demonstrated these spatial shifts tested patients in the chronic phase. For 
example, Mikulis et al. studied tetraplegic TSCI patients in the chronic phase 
and showed that when these patients moved their tongue, primary motor cortex 
activation was shifted medially and posteriorly into the upper limb represen-
tation region (Mikulis et al., 2002). Several investigators have proposed that a 
similar shift takes place among paralyzed patients when they move their hand 
(Curt et al., 2002; Kokotilo et al., 2009a; Lotze et al., 1999). It has been argued 
that representation migrates superiorly and medially, since it borders on the 
adjacent disconnected upper or lower extremity cortex (Kokotilo et al., 2009a). 
The possible causes of the changes are destroyed sensorimotor tracts, disruption 
of lateral inhibitory network in the cortex, modification of neuronal activity 
(Mikulis et al., 2002; Streletz et al., 1995). 
Methodically, the hand motor task that we have used was more complex than 
those used in many other studies. The patients with TSCI were able to perform 
the hand task but there was a significant reduction in force and speed of move-
ments. Patients with a complete injury performed movements only by the wrist. 
Hence, we speculated that by supporting the proximal arm muscles there would 
be a medial shift of activation as well as a decreased volume of activation. 
Surprisingly, there occurred an opposite shift among the patients who recovered 
and their VOA was larger compared with that of the control subjects.  
Our results demonstrate a shift towards intact face representation during 
hand movement, while the shift is opposite to hand movement during ankle 
movement. As a result, the COG shifts towards cortical representation of the 
toes. We are not aware whether there occurs invasion of the cortical represen-
tation of the affected body part exactly into the zone of the face or the toes but, 
contrary to other studies, shifts in different directions were noticed during the 
first year. Our acute phase findings appear to be well supported by a previous 
report suggesting that the cortical representation of body parts is continuously 
changing depending on activity, the location of lesion in the nervous system, or 
the new skills learned (Chen et al., 2002). 
Patients with TSCI and stroke share several aspects of brain reorganisation 
following injury (Kokotilo et al., 2009b). The more severe the hand motor 
deficit, the greater is the shift of primary motor cortex activation towards the 
contralateral hemisphere (i.e. ipsilateral to the deficit) balance (Kokotilo et al., 
2009b).  According to wLI, cortical activation during hand movement was less 
lateralised among the patients than among controls in our study. Lower limb 
cortical representation occupies a smaller and medial spatial extent in the 
primary cortex, which may have been the main cause of non-significant wLI 
differences during ankle movement among the patients and the controls. As the 
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sample was small, we did not find any statistically significant difference in 
laterality regarding recovery.  
Contrary to earlier studies (Freund et al., 2011), we can conclude that 
cortical functional reorganisation is larger among the patients who recover.  
There were some limitations to the study. As we did not image the spinal 
cord, it was not possible to correlate the size of the damaged area with cortical 
reorganisation.  
The number of patients was quite small in our study and the results would 
have been more conclusive when there have been more patients with cervical 
TSCI. What we know about the cortical reorganisation is largely based on a 
small number of cases because of the strict inclusion and exclusion criteria 
(Kokotilo et al., 2009a). The patients had to be medically stable during imaging 
and were not allowed to have concomitant traumatic brain injury. We were able 
to study every patient regularly at  given time points. However, there was also 
more activation in the associated cortical sensorimotor areas of the controls in 
our study compared with other studies.  
In conclusion, our results show that compensatory changes of brain function 
take place during the first post-TSCI year. The increase of VOA is more 
extensive among the patients who recover.  
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7. CONCLUSIONS 
The epidemiological state of TSCI is “bittersweet”. Although the incidence of 
TSCI is relatively low and the numbers are presented as per million population 
per year, most victims are young men in their highly productive period of life. 
When TSCI has occurred, it represents one of the most devastating injuries of 
the human body, usually with lifelong disability. 
 
Paper I 
Compared to recent studies from Europe where the incidence of TSCI is 
between 15 and 30 per million population the incidence of TSCI in Estonia 
(39.7 per million) is among the highest. The rates are significantly higher for 
men compared with women and especially among the youngest men (age-group 
16 to 30 years). The leading cause of TSCI is falls. A significant proportion of 
injuries are related to alcohol consumption before trauma in Estonia. 
 
Paper II 
Although the two cohorts, Estonia and Western Norway, have similar demo-
graphic, injury and clinical characteristics, the age profile of the victims is 
different. The incidence rate is 1.5 times higher and SMR is 2.7 times higher in 
Estonia. Probable explanations for the different outcomes of the two European 
countries are socioeconomic differences, lower physical activity level, lower 
life expectancy and insufficient injury prevention programs in Estonia.  
 
Paper III 
Life expectancy is significantly decreased in TSCI patients compared with the 
general population in Estonia. Deaths during the first year after the injury have 
an important impact on survival. Treatment of cardiovascular diseases, infec-
tions and prevention of suicides are useful for reducing mortality among TSCI 
patients. 
 
Paper IV 
The study found broadening of cortical activation and a shift of COG during the 
first year after TSCI depending on the recovery. To our knowledge this is the 
first study to show the dynamic changes of activation in the acute phase of 
TSCI.  
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9. SUMMARY IN ESTONIAN 
Seljaajutraumade epidemioloogia Eestis.  
Peaaju aktivatsioonimuster seljaajutrauma ägedas faasis 
 
Seljaajutrauma (SAT) tõttu invaliidistub maailmas igal aastal üle saja tuhande 
inimese. Lisaks märkimisväärsele eluaegsele puudele on SAT-l mõju ka inime-
se elukvaliteedile ning elulemusele. Epidemioloogilised SAT-uurimused said 
alguse umbes 40 aastat tagasi (Wyndaele ja Wyndaele, 2006).  
SAT haigestumuskordajad erinevad riigiti. Arenenud riikide haigestumus-
kordajad on arenguriikidest suuremad ning seda seletatakse andmete erineva 
kättesaadavuse, meditsiinilise abi taseme ning üldise erineva elukvaliteediga 
(Chiu jt, 2010). SAT-haigestumus on avaldatud andmete kohaselt Euroopas 
10,4 (van Asbeck jt, 2000) kuni 57,8 (Martins jt, 1998); Põhja-Ameerikas 27,1 
(Burke jt, 2001) kuni 83 (Warren jt, 1995); Aasias 18 (Chen jt, 1997) kuni 40,2 
(Shingu jt, 1995) ning Austraalias 14,5 (O’Connor, 2002) juhtu miljoni inim-
aasta kohta.  
Varasemate uuringutega on näidatud, et SAT haigestumuskordajad on suuri-
mad nooremates vanuserühmades (Wyndaele ja Wyndaele, 2006; van den Berg, 
2010). Hiljutiste uuringute tulemusel on leitud ka, et haigestumises on tekkinud 
2 haripunkti: esimene suurem haigestumine leiab aset vanuserühmas 15–29 aas-
tat, teine aga  65-aastaste seas (Wyndaele ja Wyndaele, 2006). SAT põhjused 
erinevad vanuserühmiti ning ka riigiti (Chiu jt, 2010). Kuigi endiselt on põh-
justest esimene liiklustrauma, on sagenema hakanud kukkumine ja seda just 
eakate hulgas (Ahoniemi jt, 2008; Couris jt, 2010; Hagen jt, 2010; Ning jt, 
2011). 
SAT-patsientide elulemus on viimaste aastakümnete jooksul suurenenud, 
sest varasemast tõhusam taastusravi võimaldab ennetada tüsistusi, nii et paljud 
patsiendid kohanevad puudega ja naasevad tavaellu. Ometi on SAT-patsientidel 
suremus tavarahvastikuga võrreldes oluliselt suurem (DeVivo jt, 1999).  
Eestis epidemioloogilised andmed SAT kohta puuduvad. Haigestumus aga 
peegeldab SAT-ennetustööd ja näitab, kas see vajab tõhustamist. Haigestumus 
koos elulemuse, tüsistuste, sotsiaalse toimetuleku ning elukvaliteeti peegelda-
vate näitajatega on väärtuslikuks allikaks tervishoiu planeerimisel ja sotsiaalabi 
korraldamisel. 
Erinevalt aastaid valitsenud arusaamast, et täiskasvanud imetajate kesknärvi-
süsteemi närvirakud pole uuenemisvõimelised, on viimasel ajal leitud, et ka 
inimese närvirakud taastuvad (Bareyre, 2008). On olemas endogeenne regene-
ratsioonivõime: isegi ilma sekkumiseta toimub 40% SAT-patsientidel kahjus-
tusest allpool osaline motoorse või sensoorse funktsiooni paranemine (Tsung ja 
Fassett, 2011). Lisaks muutustele trauma piirkonnas ehk seljaajus leiavad aset 
ümberkorraldused ka peaajus. Närvisüsteemi plastilisust on uuritud insuldi ja 
ajutraumaga patsientidel, kuid vähem seljaajutraumaga patsientidel. Neuroradio-
loogiliste uuringutega (funktsionaalne magnetresonantstomograafia (fMRT), 
positronemissioontomograafia (PET), elektroentsefalograafia (EEG), trans-
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kraniaalne magnetstimulatsioon (TMS), magnetentsefalograafia (MEG)) on 
täheldatud muutusi peaaju aktivatsioonis ka SAT järel neil patsientidel, kellel 
kaasuvat peaajukahjustust ei ole. Peaaju funktsioonide reorganisatsioon kesk-
närvisüsteemi kahjustuse järel on üks põhilisi sensomotoorse funktsiooni 
taastumise mehhanisme (Kokotilo jt, 2009a).  
Varasemate uuringutega ei ole motoorse ajukoore aktivatsioonimustri kuju-
nemist ja muutusi SAT järel täielikult välja selgitatud. Erinevate uuringute 
metoodika kui ka uuritavate rühmad pole sageli omavahel võrreldavad. On 
leitud nii seda, et motoorse ajukoore aktivatsioon SAT-patsientidel suureneb, 
kui ka seda, et muutust ei toimu või et aktivatsioon hoopis väheneb. Ka jäse-
mete liigutused, mida patsientidel on palutud motoorse ajukoore aktivatisooni 
hindamiseks uuringu ajal teha, on väga erinevad ning mõnedes uuringutes pole 
olnud võrdluseks kontrollrühma (Kokotilo jt, 2009a). 
Seni tehtud uuringud on enamasti läbilõikeuuringud, kus on hinnatud aju 
aktivatsioonimustrit ühel ajahetkel ja enamasti juba kroonilises staadiumis 
patsientidel (Curt jt, 2002; Mikulis jt, 2002; Cramer jt, 2005; Lotze jt, 1999). 
Jurkiewicz jt hindasid patsiente esimese traumajärgse aasta vältel ja leidsid, et 
SAT ägedas perioodis, kui jäseme liigutus pole täielik, väheneb aktivatsioon 
primaarses motoorses ajukoores (PMK) ning suureneb sensomotoorsetel lisa-
aladel (motoorne lisaala, tsingulaarne motoorne ala, premotoorne koor, parie-
taalne ajukoor), motoorika paranedes aga suureneb PMK aktivatsioon uuesti, 
seevastu sensomotoorsetel lisaaladel väheneb (Jurkiewicz jt, 2007).  
Samad autorid uurisid püsiva neuroloogilise leiuga SAT-patsiente esimese 
traumajärgse aasta jooksul ka korduvalt. Võrreldes tervete kontrollisikutega ei 
olnud PMK aktivatsioonis muutusi, lisaalade aktivatsioon aga laienes sarnaselt 
eespool mainitud uuringuga. Tetrapleegia püsimisel vähenes aasta jooksul ka 
lisaalade aktivatsioon (Jurkiewicz jt, 2010).  
 
 
Uurimuse eesmärgid 
 
 Leida SAT haigestumuskordaja ja hinnata selle muutust (I publikatsioon). 
 Analüüsida kogu Eesti rahvastikust leitud SAT-patsientide isikuandmeid ja 
kliinilisi omadusi aastatel 1997 kuni 2007 (I publikatsioon). 
 Võrrelda SAT-patsientide haigestumust ja elulemust Eestis ning Lääne-
Norras aastatel 1997 kuni 2007 (II publikatsioon). 
 Uurida SAT-patsientide suremust ja surmapõhjusi (III publikatsioon). 
 Leida ajukoore aktivatsioonimustri muutused seljaaju kaelaosa kahjustusega 
patsientidel esimese traumajärgse aasta jooksul (IV publikatsioon). 
 
 
Patsiendid ja meetodid 
 
Retrospektiivselt vaadati läbi aastatel 1997–2007 kõikides Eesti regionaal-
haiglates, keskhaiglates, üldhaiglates, maakonnahaiglates ja taastusravi keskus-
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tes (kokku 22 haiglat) RHK-10 diagnoosikoodidega S12.0, S12.1, S12.2, S12.7, 
S13.0, S13.2, S13.4, S14.0, S14.1, S22.0, S23.0, S23.1, S24.0, S24.1, S32.0, 
S33.01, S34.0, S34.1, S34.3, T06.0, T06.1, T09.3, T91.1, T91.3 ravil olnud 
kõikides vanustes patsientide haiguslood. Iga patsiendi kohta täideti protokoll, 
mis sisaldas isikuandmeid, andmeid trauma põhjuste ja sellega seotud asjaolude 
kohta, radioloogilist diagnoosi, neuroloogilisi sümptomeid ning muid medit-
siinilisi andmeid.  
31. detsembri 2011. aasta seisuga saadi haiglajärgse surma fakti ja kuupäeva 
andmed rahvastikuregistrist. Surnud patsientide andmed on lingitud surma-
põhjuste registrist saadud surmapõhjustega.  
IV publikatsioonis kajastatud uuringusse kaasati Tartu Ülikooli Kliinikumis 
2010. aasta maikuust kuni augustini seljaaju kaelaosa traumaga ravil viibinud 
patsiendid, kelle neuroloogiline defitsiit püsis üle 1 nädala. Patsiendid pidid 
uuringu ajaks olema stabiilses üldseisundis. Kõik uuritud andsid ka osalemiseks 
nõusoleku. Uuringust jäid välja kaasuva peatraumaga patsiendid; patsiendid, 
kellel oli varem diagnoositud epilepsia; ning need, kellele oli MRT-uuring 
vastunäidustatud.  
fMRT tehti 1,5 T aparaadiga Tartu Ülikooli Kliinikumi radioloogiakliinik. 
Peaajukoore aktivatsioonimustrit hinnati patsientidel ägedas perioodis 1 kuu 
pärast traumat, seejärel 3 kuu ja 1 aasta möödudes. fMRT-uuring tehti ka 12 
tervele vabatahtlikule, kelle vanus ja sugu vastas SAT-patsientidele (± 2 aastat) 
ning kes olid paremakäelised. Neist 7 kontrollisikul korrati uuringut aasta 
möödudes.  
Uuritavatel tuli uuringu ajal sooritada (või üritada sooritada) parema laba-
käega ja sõrmedega pigistusliigutus ning parema labajala fleksioon ja eksten-
sioon. Liigutused tehti soovitavalt 1 Hz kiirusega 40-sekundiliste tsüklitena, 
millele järgnesid pausid. 
Uuringute andmed töödeldi statistiliselt tarkvaraga SPM (versioon 8), 
aktivatsioonialad kujutati nn normeeritud templaatkujutistel. Lisaks arvutati 
patsientidele lateralisatsioonikõverad erinevate olulisusenivoo väärtustega. 
Statistiliseks analüüsiks kasutati vabavaraprogrammi R ja programmi 
StatsDirect. Olulisuse nivooks oli kõikides arvutustes 5%. 
 
 
Peamised tulemused 
 
Läbi vaadati üle 3000 haigusloo 22 Eesti haiglas. Kokku registreeriti aastatel 
1997 kuni 2007 595 seljaajutrauma juhtu. Aastane standardimata esmashaiges-
tumuskordaja oli 39,7 juhtu miljoni inimaasta kohta (95% usaldusvahemik (uv) 
36,6–43,0), mis on üks kõrgemaid Euroopas. Standardides andmed vanuse järgi 
Eesti rahvastikule, oli haigestumuskordaja 39,4 ning seda 72,0 miljoni inim-
aasta kohta meeste hulgas ja 11,5 miljoni inimaasta kohta naiste hulgas. Hai-
gestumus oli oluliselt suurem meeste hulgas (haigestumusmäärade suhe (IRR) 
6,4; 95% uv 5,1–8,1; p = 0,003). Vaadeldud ajaperioodi vältel ei esinenud 
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statistiliselt olulist muutust haigestumuskordajates (IRR 1,02; 95% uv 1,00–
1,05; p = 0,09).  
Keskmine vanus SAT-patsientidel oli 39,0 aastat. Alkoholi oli enne traumat 
tarvitanud 43,2% patsientidest. Peamine traumapõhjus oli kukkumine (41,0%), 
millele järgnesid liiklustrauma (29,4%) ning sporditraumad (14,0%).  
31. detsembriks 2011 oli 595 traumapatsiendist surnud 162. Surnute vanus 
SAT ajal oli kõrgem võrreldes ellujäänutega (50,1 ± 18,0 vs. 34,8 ± 14,6). Pea-
aegu pooled surmadest toimusid esimesel traumajärgsel aastal. Esimesel aastal 
oli põhiliseks surmapõhjuseks traumast tingitud väline põhjus (52,6%), hiljem 
olid ülekaalus kardiovaskulaarsed haigused (35,6%) ning suitsiidid (13,8%).  
Üldine standarditud suremusmäär (SMR) oli 2,81 (2,40–3,28) ning erinevalt 
paljudest teistest riikidest oli SMR Eestis naistel suurem kui meestel. Surma 
põhjusespetsiifiline SMR oli suurim sepsise korral. Ainus surma põhjus, mida 
esines SAT-patsientidel harvem võrreldes tavarahvastikuga, oli kasvajaline 
haigus. 
Hulgitunnusanalüüsil Coxi regressioonimudeli järgi olid kahe esimese SAT-
le järgneva aasta vältel olulisteks surma riskiteguriteks vanus, tservikaalne SAT, 
täielik seljaajukahjustus ning kaasuv trauma. Esimesel traumajärgsel aastal oli 
suurem risk surra kaelaosakahjustusega patsientidel, kelle kahjustus oli 1.–4. 
kaelalüli kõrgusel ning kellel oli Ameerika spinaaltrauma ühingu (AIS) kah-
justuse skaala järgi A, B või C astme kahjustus (ASIA, 2011).  
IV publikatsioonis tutvustatud uuringust selgus, et esimesel traumajärgsel 
aastal leiavad ajukoore aktivatsioonimustris aset olulised muutused. Funktsio-
naalsest paranemisest lähtudes muutub ka aktivatsioonimuster. Paranejate aju-
koore aktivatsioonimahud olid oluliselt suuremad esimestel traumajärgsetel 
kuudel, esimese aasta lõpus olid need aga jõudnud samale tasemele kontrollide 
ning sügava tetrapareesiga patsientidega. Lisaks leiti, et paranejate akti-
vatsioonimuster nihkus käe liigutamisel lateraalsele, anterioorsele ning infe-
rioorsele ehk näo primaarsesse korteksisse. Samas nihkus jala liigutamisel tsen-
ter hoopis mediaalsele ehk varvaste motoorsesse korteksisse.  
SAT-patsientide kortikaalne aktivatsioon oli võrreldes kontrollidega vähem 
lateraliseerunud. Erinevalt varasematest uuringutest võib saadud tulemuste 
põhjal väita, et paranejatel on peaajukoore aktivatsioon laialdasem ja intensiiv-
sem. Seetõttu võib arvata, et fMRT on SAT-patsientide funktsionaalse tulemuse 
potentsiaalne prognoosija.  
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11. APPENDICES 
Appendix A. American Spinal Injury Association Impairment Scale (permis-
sion to publish the chart has been obtained from ASIA). 
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Appendix B. American Spinal Injury Association Impairment Scale (permission to 
publish the chart has been obtained from ASIA). 
 
 
 
  
  
 
 
 
12. PUBLICATIONS 
 
  
CURRICULUM VITAE 
Name:  Liis Sabre 
Date of birth:  23.09.1983, Tartu, Estonia 
Citizenship:  Estonian 
Address:  8 L. Puusepa Street, 51014, Tartu, Estonia 
Phone:  (+372) 731 8552 
Fax:   (+372) 731 8509 
E-mail:  Liis.Sabre@ut.ee 
 
Education 
1990‒1997 Tartu Veeriku School 
1997‒2002 Tartu Miina Härma Secondary School 
2002‒2003 University of Tartu, Faculty of  Social Sciences and Education, 
Psychology 
2003‒2009 University of Tartu, Faculty of Medicine, Degree in Medicine, 
cum laude 
2009‒  University of Tartu, Faculty of Medicine, Residency training in 
neurology  
2010‒ University of Tartu, Faculty of Medicine, PhD studies in 
neurology 
 
Professional employment 
2005–2007 Tartu University Hospital, Internal Medicine Clinic, 
Department of the Nephrology; nurse 
2007–2009 Tartu University Hospital, Anaesthesiology and Intensive Care 
Clinic, Department of the General Intensive Care; nurse 
 
Scientific work and professional organisations 
Research fields: Headache and pain, neurodegenerative disorders, traumas 
Publications: 4 international, 6 domestic 
Membership:  International Spinal  Cord Society – member 
Movement Disorder Society – member 
European Federation of  Neurological Societies – member 
Estonian Headache Society – secretary 
  Estonian Movement Disorders Society – member 
  Estonian Junior Doctors Association – member 
 
123 
ELULOOKIRJELDUS 
Nimi:  Liis Sabre 
Sünniaeg:  23.09.1983, Tartu, Eesti 
Kodakondsus:  Eesti 
Aadress:  Puusepa 8H, 51014, Tartu 
Telefon:  731 8552 
Faks: 731 8509 
E-post:  Liis.Sabre@ut.ee 
 
Hariduskäik 
1990‒1997 Tartu Veeriku kool 
1997‒2002  Miina Härma Gümnaasium 
2002‒2003  Tartu Ülikool, Sotsiaalteaduskond, psühholoogia 
2003‒2009  Tartu Ülikool, Arstiteaduskond, arstiteadus (cum laude) 
2009‒ Tartu Ülikool, Arstiteaduskond, neuroloogia eriala residentuur 
2010‒  Tartu Ülikool, Arstiteaduskond, arstiteadus, doktoriõpe 
 
Töökogemus 
2005‒2007 SA Tartu Ülikooli Kliinikum, Sisekliinik, Nefroloogia 
osakond; abiõde  
2007‒2009 SA TÜK Anestesioloogia- ja intensiivravi kliinik, 
Üldintensiivravi osakond; intensiivraviabiõde 
 
Teadus- ja erialane tegevus 
Valdkonnad:  Peavalu ja valu, neurodegeneratiivsed haigused, traumad 
Publikatsioonid:  4 rahvusvahelistes, 6 kohalikes meditsiiniajakirjades 
Liikmelisus:  International Spinal  Cord Society – liige 
Movement Disorder Society – liige 
European Federation of  Neurological Societies – liige 
Eesti Peavalu Selts – sekretär 
 Eesti Liigutushäirete Selts – liige 
Eesti Nooremarstide Ühendus – liige 
 
124 
125 
DISSERTATIONES MEDICINAE  
UNIVERSITATIS TARTUENSIS 
 
 1. Heidi-Ingrid Maaroos. The natural course of gastric ulcer in connection 
with chronic gastritis and Helicobacter pylori. Tartu, 1991. 
 2. Mihkel Zilmer. Na-pump in normal and tumorous brain tissues: Structu-
ral, functional and tumorigenesis aspects. Tartu, 1991. 
 3. Eero Vasar. Role of cholecystokinin receptors in the regulation of beha-
viour and in the action of haloperidol and diazepam. Tartu, 1992. 
 4. Tiina Talvik. Hypoxic-ischaemic brain damage in neonates (clinical, 
biochemical and brain computed tomographical investigation). Tartu, 1992. 
 5. Ants Peetsalu. Vagotomy in duodenal ulcer disease: A study of gastric 
acidity, serum pepsinogen I, gastric mucosal histology and Helicobacter 
pylori. Tartu, 1992. 
 6. Marika Mikelsaar. Evaluation of the gastrointestinal microbial ecosystem 
in health and disease. Tartu, 1992. 
 7. Hele Everaus. Immuno-hormonal interactions in chronic lymphocytic leu-
kaemia and multiple myeloma. Tartu, 1993. 
 8. Ruth Mikelsaar. Etiological factors of diseases in genetically consulted 
children and newborn screening: dissertation for the commencement of the 
degree of doctor of medical sciences. Tartu, 1993. 
 9. Agu Tamm. On metabolic action of intestinal microflora: clinical aspects. 
Tartu, 1993. 
 10. Katrin Gross. Multiple sclerosis in South-Estonia (epidemiological and 
computed tomographical investigations). Tartu, 1993. 
 11. Oivi Uibo. Childhood coeliac disease in Estonia: occurrence, screening, 
diagnosis and clinical characterization. Tartu, 1994. 
 12. Viiu Tuulik. The functional disorders of central nervous system of che-
mistry workers. Tartu, 1994. 
 13. Margus Viigimaa. Primary haemostasis, antiaggregative and anticoagulant 
treatment of acute myocardial infarction. Tartu, 1994. 
 14. Rein Kolk. Atrial versus ventricular pacing in patients with sick sinus 
syndrome. Tartu, 1994. 
 15. Toomas Podar. Incidence of childhood onset type 1 diabetes mellitus in 
Estonia. Tartu, 1994. 
 16. Kiira Subi. The laboratory surveillance of the acute respiratory viral 
infections in Estonia. Tartu, 1995. 
17. Irja Lutsar. Infections of the central nervous system in children (epidemi-
ologic, diagnostic and therapeutic aspects, long term outcome). Tartu, 1995. 
18. Aavo Lang. The role of dopamine, 5-hydroxytryptamine, sigma and 
NMDA receptors in the action of antipsychotic drugs. Tartu, 1995. 
19.  Andrus Arak. Factors influencing the survival of patients after radical 
surgery for gastric cancer. Tartu, 1996. 
126 
20.  Tõnis Karki. Quantitative composition of the human lactoflora and 
method for its examination. Tartu, 1996. 
21. Reet Mändar. Vaginal microflora during pregnancy and its transmission 
to newborn. Tartu, 1996.  
22. Triin Remmel. Primary biliary cirrhosis in Estonia: epidemiology, clinical 
characterization and prognostication of the course of the disease. Tartu, 
1996. 
23. Toomas Kivastik. Mechanisms of drug addiction: focus on positive rein-
forcing properties of morphine. Tartu, 1996.  
24.  Paavo Pokk. Stress due to sleep deprivation: focus on GABAA receptor-
chloride ionophore complex. Tartu, 1996. 
25. Kristina Allikmets. Renin system activity in essential hypertension. As-
sociations with atherothrombogenic cardiovascular risk factors and with 
the efficacy of calcium antagonist treatment. Tartu, 1996. 
26. Triin Parik. Oxidative stress in essential hypertension: Associations with 
metabolic disturbances and the effects of calcium antagonist treatment. 
Tartu, 1996. 
27.  Svetlana Päi. Factors promoting heterogeneity of the course of rheumatoid 
arthritis. Tartu, 1997.  
28. Maarike Sallo. Studies on habitual physical activity and aerobic fitness in 
4 to 10 years old children. Tartu, 1997. 
29. Paul Naaber. Clostridium difficile infection and intestinal microbial eco-
logy. Tartu, 1997. 
30. Rein Pähkla. Studies in pinoline pharmacology. Tartu, 1997. 
31. Andrus Juhan Voitk. Outpatient laparoscopic cholecystectomy. Tartu, 1997. 
32. Joel Starkopf. Oxidative stress and ischaemia-reperfusion of the heart. 
Tartu, 1997. 
33.  Janika Kõrv. Incidence, case-fatality and outcome of stroke. Tartu, 1998. 
34. Ülla Linnamägi. Changes in local cerebral blood flow and lipid peroxida-
tion following lead exposure in experiment. Tartu, 1998. 
35. Ave Minajeva. Sarcoplasmic reticulum function: comparison of atrial and 
ventricular myocardium. Tartu, 1998. 
36. Oleg Milenin. Reconstruction of cervical part of esophagus by revascular-
ised ileal autografts in dogs. A new complex multistage method. Tartu, 
1998. 
37. Sergei Pakriev. Prevalence of depression, harmful use of alcohol and 
alcohol dependence among rural population in Udmurtia. Tartu, 1998. 
38. Allen Kaasik. Thyroid hormone control over -adrenergic signalling 
system in rat atria. Tartu, 1998. 
39. Vallo Matto. Pharmacological studies on anxiogenic and antiaggressive 
properties of antidepressants. Tartu, 1998. 
40. Maire Vasar. Allergic diseases and bronchial hyperreactivity in Estonian 
children in relation to environmental influences. Tartu, 1998. 
127 
41. Kaja Julge. Humoral immune responses to allergens in early childhood. 
Tartu, 1998. 
42. Heli Grünberg. The cardiovascular risk of Estonian schoolchildren. 
A cross-sectional study of 9-, 12- and 15-year-old children. Tartu, 1998. 
43. Epp Sepp. Formation of intestinal microbial ecosystem in children. Tartu, 
1998. 
44. Mai Ots. Characteristics of the progression of human and experimental 
glomerulopathies. Tartu, 1998. 
45. Tiina Ristimäe. Heart rate variability in patients with coronary artery 
disease. Tartu, 1998. 
46. Leho Kõiv. Reaction of the sympatho-adrenal and hypothalamo-pituitary-
adrenocortical system in the acute stage of head injury. Tartu, 1998. 
47. Bela Adojaan. Immune and genetic factors of childhood onset IDDM in 
Estonia. An epidemiological study. Tartu, 1999. 
48. Jakov Shlik. Psychophysiological effects of cholecystokinin in humans. 
Tartu, 1999. 
49. Kai Kisand. Autoantibodies against dehydrogenases of -ketoacids. Tartu, 
1999. 
50. Toomas Marandi. Drug treatment of depression in Estonia. Tartu, 1999. 
51. Ants Kask. Behavioural studies on neuropeptide Y. Tartu, 1999. 
52. Ello-Rahel Karelson. Modulation of adenylate cyclase activity in the rat 
hippocampus by neuropeptide galanin and its chimeric analogs. Tartu, 1999. 
53. Tanel Laisaar. Treatment of pleural empyema — special reference to 
intrapleural therapy with streptokinase and surgical treatment modalities. 
Tartu, 1999. 
54. Eve Pihl. Cardiovascular risk factors in middle-aged former athletes. 
Tartu, 1999. 
55.  Katrin Õunap. Phenylketonuria in Estonia: incidence, newborn screening, 
diagnosis, clinical characterization and genotype/phenotype correlation. 
Tartu, 1999. 
56. Siiri Kõljalg. Acinetobacter – an important nosocomial pathogen. Tartu, 
1999. 
57. Helle Karro. Reproductive health and pregnancy outcome in Estonia: 
association with different factors. Tartu, 1999. 
58. Heili Varendi. Behavioral effects observed in human newborns during 
exposure to naturally occurring odors. Tartu, 1999.  
59. Anneli Beilmann. Epidemiology of epilepsy in children and adolescents in 
Estonia. Prevalence, incidence, and clinical characteristics. Tartu, 1999. 
60. Vallo Volke. Pharmacological and biochemical studies on nitric oxide in 
the regulation of behaviour. Tartu, 1999. 
61.  Pilvi Ilves. Hypoxic-ischaemic encephalopathy in asphyxiated term infants. 
A prospective clinical, biochemical, ultrasonographical study. Tartu, 1999. 
62. Anti Kalda. Oxygen-glucose deprivation-induced neuronal death and its 
pharmacological prevention in cerebellar granule cells. Tartu, 1999. 
1 8 
63.  Eve-Irene Lepist. Oral peptide prodrugs – studies on stability and 
absorption. Tartu, 2000. 
64. Jana Kivastik. Lung function in Estonian schoolchildren: relationship 
with anthropometric indices and respiratory symptomas, reference values 
for dynamic spirometry. Tartu, 2000. 
65. Karin Kull. Inflammatory bowel disease: an immunogenetic study. Tartu, 
2000. 
66. Kaire Innos. Epidemiological resources in Estonia: data sources, their 
quality and feasibility of cohort studies. Tartu, 2000. 
67. Tamara Vorobjova. Immune response to Helicobacter pylori and its 
association with dynamics of chronic gastritis and epithelial cell turnover 
in antrum and corpus. Tartu, 2001. 
68. Ruth Kalda. Structure and outcome of family practice quality in the 
changing health care system of Estonia. Tartu, 2001. 
69. Annika Krüüner. Mycobacterium tuberculosis – spread and drug 
resistance in Estonia. Tartu, 2001. 
70. Marlit Veldi. Obstructive Sleep Apnoea: Computerized Endopharyngeal 
Myotonometry of the Soft Palate and Lingual Musculature. Tartu, 2001. 
71. Anneli Uusküla. Epidemiology of sexually transmitted diseases in Estonia 
in 1990–2000. Tartu, 2001. 
72. Ade Kallas. Characterization of antibodies to coagulation factor VIII. 
Tartu, 2002. 
73. Heidi Annuk. Selection of medicinal plants and intestinal lactobacilli as 
antimicrobil components for functional foods. Tartu, 2002.  
74. Aet Lukmann. Early rehabilitation of patients with ischaemic heart 
disease after surgical revascularization of the myocardium:  assessment of 
health-related quality of life, cardiopulmonary reserve and oxidative stress. 
A clinical study. Tartu, 2002. 
75. Maigi Eisen. Pathogenesis of Contact Dermatitis: participation of Oxida-
tive Stress. A clinical – biochemical study. Tartu, 2002. 
76. Piret Hussar. Histology of the post-traumatic bone repair in rats. Elabora-
tion and use of a new standardized experimental model – bicortical perfora-
tion of tibia compared to internal fracture and resection osteotomy. Tartu, 
2002. 
77. Tõnu Rätsep. Aneurysmal subarachnoid haemorrhage: Noninvasive moni-
toring of cerebral haemodynamics. Tartu, 2002. 
78. Marju Herodes. Quality of life of people with epilepsy in Estonia. Tartu, 
2003. 
79. Katre Maasalu. Changes in bone quality due to age and genetic disorders 
and their clinical expressions in Estonia. Tartu, 2003. 
80. Toomas Sillakivi. Perforated peptic ulcer in Estonia: epidemiology, risk 
factors and relations with Helicobacter pylori. Tartu, 2003. 
81. Leena Puksa. Late responses in motor nerve conduction studies. F and A 
waves in normal subjects and patients with neuropathies. Tartu, 2003. 
2
129 
82. Krista Lõivukene. Helicobacter pylori in gastric microbial ecology and  
its antimicrobial susceptibility pattern. Tartu, 2003. 
83. Helgi Kolk. Dyspepsia and Helicobacter pylori infection: the diagnostic 
value of symptoms, treatment and follow-up of patients referred for upper 
gastrointestinal endoscopy by family physicians. Tartu, 2003. 
84. Helena Soomer. Validation of identification and age estimation methods 
in forensic odontology. Tartu, 2003. 
85. Kersti Oselin. Studies on the human MDR1, MRP1, and MRP2 ABC 
transporters: functional relevance of the genetic polymorphisms in the 
MDR1 and MRP1 gene. Tartu, 2003. 
86. Jaan Soplepmann. Peptic ulcer haemorrhage in Estonia: epidemiology, 
prognostic factors, treatment and outcome. Tartu, 2003. 
87. Margot Peetsalu. Long-term follow-up after vagotomy in duodenal ulcer 
disease: recurrent ulcer, changes in the function, morphology and Helico-
bacter pylori colonisation of the gastric mucosa. Tartu, 2003. 
88. Kersti Klaamas. Humoral immune response to Helicobacter pylori a study 
of host-dependent and microbial factors. Tartu, 2003. 
89. Pille Taba. Epidemiology of Parkinson’s disease in Tartu, Estonia. Pre-
valence, incidence, clinical characteristics, and pharmacoepidemiology. 
Tartu, 2003.  
90. Alar Veraksitš. Characterization of behavioural and biochemical pheno-
type of cholecystokinin-2 receptor deficient mice: changes in the function 
of the dopamine and endopioidergic system. Tartu, 2003. 
91. Ingrid Kalev. CC-chemokine receptor 5 (CCR5) gene polymorphism in 
Estonians and in patients with Type I and Type II diabetes mellitus. Tartu, 
2003. 
92. Lumme Kadaja. Molecular approach to the regulation of mitochondrial 
function in oxidative muscle cells. Tartu, 2003. 
93. Aive Liigant. Epidemiology of primary central nervous system tumours in 
Estonia from 1986 to 1996. Clinical characteristics, incidence, survival and 
prognostic factors. Tartu, 2004. 
94. Andres, Kulla. Molecular characteristics of mesenchymal stroma in 
human astrocytic gliomas. Tartu, 2004. 
95. Mari Järvelaid. Health damaging risk behaviours in adolescence. Tartu, 
2004. 
96. Ülle Pechter. Progression prevention strategies in chronic renal failure and 
hypertension. An experimental and clinical study. Tartu, 2004. 
97. Gunnar Tasa. Polymorphic glutathione S-transferases – biology and role 
in modifying genetic susceptibility to senile cataract and primary open 
angle glaucoma. Tartu, 2004. 
98. Tuuli Käämbre. Intracellular energetic unit: structural and functional 
aspects. Tartu, 2004. 
130 
99.  Vitali Vassiljev. Influence of nitric oxide syntase inhibitors on the effects  
of ethanol after acute and chronic ethanol administration and withdrawal. 
Tartu, 2004. 
100. Aune Rehema. Assessment of nonhaem ferrous iron and glutathione 
redox ratio as markers of pathogeneticity of oxidative stress in different 
clinical groups. Tartu, 2004. 
101.   Evelin Seppet. Interaction of mitochondria and ATPases in oxidative 
muscle cells in normal and pathological conditions. Tartu, 2004. 
102. Eduard Maron. Serotonin function in panic disorder: from clinical expe-
riments to brain imaging and genetics. Tartu, 2004.  
103. Marje Oona. Helicobacter pylori infection in children: epidemiological 
and therapeutic aspects. Tartu, 2004. 
104. Kersti Kokk. Regulation of active and passive molecular transport in the 
testis. Tartu, 2005.  
105. Vladimir Järv. Cross-sectional imaging for pretreatment evaluation and 
follow-up of pelvic malignant tumours. Tartu, 2005. 
106. Andre Õun. Epidemiology of adult epilepsy in Tartu, Estonia. Incidence, 
prevalence and medical treatment. Tartu, 2005. 
107. Piibe Muda. Homocysteine and hypertension: associations between 
homocysteine and essential hypertension in treated and untreated hyper-
tensive patients with and without coronary artery disease. Tartu, 2005. 
108. Külli Kingo. The interleukin-10 family cytokines gene polymorphisms in 
plaque psoriasis. Tartu, 2005.  
109. Mati Merila. Anatomy and clinical relevance of the glenohumeral joint  
capsule and ligaments. Tartu, 2005. 
110. Epp Songisepp. Evaluation of technological and functional properties of 
the new probiotic Lactobacillus fermentum ME-3. Tartu, 2005. 
111. Tiia Ainla. Acute myocardial infarction in Estonia: clinical characte-
ristics, management and outcome. Tartu, 2005. 
112. Andres Sell. Determining the minimum local anaesthetic requirements for 
hip replacement surgery under spinal anaesthesia – a study employing a 
spinal catheter. Tartu, 2005. 
113. Tiia Tamme. Epidemiology of odontogenic tumours in Estonia. Patho-
genesis and clinical behaviour of ameloblastoma. Tartu, 2005. 
114. Triine Annus. Allergy in Estonian schoolchildren: time trends and 
characteristics. Tartu, 2005. 
115. Tiia Voor. Microorganisms in infancy and development of allergy: com-
parison  of  Estonian  and Swedish  children. Tartu, 2005. 
116. Priit Kasenõmm. Indicators for tonsillectomy in adults with recurrent 
tonsillitis – clinical, microbiological and pathomorphological investi-
gations. Tartu, 2005. 
117. Eva Zusinaite. Hepatitis C virus: genotype identification and interactions 
between viral proteases. Tartu, 2005. 
131 
118. Piret Kõll. Oral lactoflora in chronic periodontitis and periodontal health. 
Tartu, 2006. 
119. Tiina Stelmach. Epidemiology of cerebral palsy and unfavourable neuro-
developmental outcome in child population of Tartu city and county, 
Estonia Prevalence, clinical features and risk factors. Tartu, 2006. 
120. Katrin Pudersell. Tropane alkaloid production and riboflavine excretion 
in the field and tissue cultures of henbane (Hyoscyamus niger L.). Tartu, 
2006.  
121. Külli Jaako. Studies on the role of neurogenesis in brain plasticity. Tartu, 
2006.  
122. Aare Märtson. Lower limb lengthening: experimental studies of bone 
regeneration and long-term clinical results. Tartu, 2006. 
123.  Heli Tähepõld. Patient consultation in family medicine. Tartu, 2006. 
124. Stanislav Liskmann. Peri-implant disease: pathogenesis, diagnosis and 
treatment in view of both inflammation and oxidative stress profiling. 
Tartu, 2006. 
125. Ruth Rudissaar. Neuropharmacology of atypical antipsychotics and an 
animal model of psychosis. Tartu, 2006. 
126. Helena Andreson. Diversity of Helicobacter pylori genotypes in 
Estonian patients with chronic inflammatory gastric diseases. Tartu, 2006. 
127. Katrin Pruus. Mechanism of action of antidepressants: aspects of sero-
toninergic system and its interaction with glutamate. Tartu, 2006. 
128. Priit Põder. Clinical and experimental investigation: relationship of 
ischaemia/reperfusion injury with oxidative stress in abdominal aortic 
aneurysm repair and in extracranial brain artery endarterectomy and possi-
bilities of protection against ischaemia using a glutathione analogue in a 
rat model of global brain ischaemia. Tartu, 2006.   
129. Marika Tammaru. Patient-reported outcome measurement in rheumatoid 
arthritis. Tartu, 2006. 
130.   Tiia Reimand. Down syndrome in Estonia. Tartu, 2006. 
131. Diva Eensoo. Risk-taking in traffic and Markers of Risk-Taking Beha-
viour in Schoolchildren and Car Drivers. Tartu, 2007. 
132. Riina Vibo. The third stroke registry in Tartu, Estonia from 2001 to 2003: 
incidence, case-fatality, risk factors and long-term outcome. Tartu, 2007.  
133. Chris Pruunsild. Juvenile idiopathic arthritis in children in Estonia. 
Tartu, 2007. 
134. Eve Õiglane-Šlik. Angelman and Prader-Willi syndromes in Estonia. 
Tartu, 2007. 
135. Kadri Haller. Antibodies to follicle stimulating hormone. Significance in 
female infertility. Tartu, 2007. 
136.  Pille Ööpik. Management of depression in family medicine. Tartu, 2007. 
137. Jaak Kals. Endothelial function and arterial stiffness in patients with 
atherosclerosis and in healthy subjects. Tartu, 2007. 
132 
138.  Priit Kampus. Impact of inflammation, oxidative stress and age on 
arterial stiffness and carotid artery intima-media thickness. Tartu, 2007. 
139.  Margus Punab. Male fertility and its risk factors in Estonia. Tartu, 2007. 
140. Alar Toom. Heterotopic ossification after total hip arthroplasty: clinical 
and pathogenetic investigation. Tartu, 2007. 
141. Lea Pehme. Epidemiology of tuberculosis in Estonia 1991–2003 with 
special regard to extrapulmonary tuberculosis and delay in diagnosis of 
pulmonary tuberculosis. Tartu, 2007. 
142.  Juri Karjagin. The pharmacokinetics of metronidazole and meropenem 
in septic shock. Tartu, 2007. 
143. Inga Talvik. Inflicted traumatic brain injury shaken baby syndrome in 
Estonia – epidemiology and outcome. Tartu, 2007. 
144.  Tarvo Rajasalu. Autoimmune diabetes: an immunological study of type 
1 diabetes in humans and in a model of experimental diabetes (in RIP-
B7.1 mice). Tartu, 2007. 
145. Inga Karu. Ischaemia-reperfusion injury of the heart during coronary 
surgery: a clinical study investigating the effect of hyperoxia. Tartu, 2007. 
146. Peeter Padrik. Renal cell carcinoma: Changes in natural history and 
treatment of metastatic disease. Tartu, 2007.  
147.  Neve Vendt. Iron deficiency and iron deficiency anaemia in infants aged 
9 to 12 months in Estonia. Tartu, 2008.  
148. Lenne-Triin Heidmets. The effects of neurotoxins on brain plasticity: 
focus on neural Cell Adhesion Molecule. Tartu, 2008. 
149.  Paul Korrovits. Asymptomatic inflammatory prostatitis: prevalence, etio-
logical factors, diagnostic tools. Tartu, 2008. 
150.   Annika Reintam. Gastrointestinal failure in intensive care patients. Tartu, 
2008. 
151.   Kristiina Roots. Cationic regulation of Na-pump in the normal, Alzhei-
mer’s and CCK2 receptor-deficient brain. Tartu, 2008. 
152. Helen Puusepp. The genetic causes of mental retardation in Estonia: 
fragile X syndrome and creatine transporter defect. Tartu, 2009. 
153. Kristiina Rull. Human chorionic gonadotropin beta genes and recurrent 
miscarriage: expression and variation study. Tartu, 2009. 
154.  Margus Eimre. Organization of energy transfer and feedback regulation 
in oxidative muscle cells. Tartu, 2009. 
155. Maire Link. Transcription factors FoxP3 and AIRE: autoantibody 
associations. Tartu, 2009. 
156.  Kai Haldre. Sexual health and behaviour of young women in Estonia. 
Tartu, 2009. 
157. Kaur Liivak. Classical form of congenital adrenal hyperplasia due to  
21-hydroxylase deficiency in Estonia: incidence, genotype and phenotype 
with special attention to short-term growth and 24-hour blood pressure. 
Tartu, 2009. 
133 
158. Kersti Ehrlich. Antioxidative glutathione analogues (UPF peptides) – 
molecular design, structure-activity relationships and testing the protec-
tive properties. Tartu, 2009. 
159. Anneli Rätsep. Type 2 diabetes care in family medicine. Tartu, 2009. 
160. Silver Türk. Etiopathogenetic aspects of chronic prostatitis: role of 
mycoplasmas, coryneform bacteria and oxidative stress. Tartu, 2009. 
161. Kaire Heilman. Risk markers for cardiovascular disease and low bone 
mineral density in children with type 1 diabetes. Tartu, 2009. 
162.  Kristi Rüütel. HIV-epidemic in Estonia: injecting drug use and quality of 
life of people living with HIV. Tartu, 2009. 
163. Triin Eller. Immune markers in major depression and in antidepressive 
treatment. Tartu, 2009. 
164.  Siim Suutre. The role of TGF-β isoforms and osteoprogenitor cells in the 
pathogenesis of heterotopic ossification. An experimental and clinical 
study of hip arthroplasty. Tartu, 2010. 
165.  Kai Kliiman. Highly drug-resistant tuberculosis in Estonia: Risk factors 
and predictors of poor treatment outcome. Tartu, 2010.  
166.  Inga Villa. Cardiovascular health-related nutrition, physical activity and 
fitness in Estonia. Tartu, 2010. 
167. Tõnis Org. Molecular function of the first PHD finger domain of Auto-
immune Regulator protein. Tartu, 2010.  
168. Tuuli Metsvaht. Optimal antibacterial therapy of neonates at risk of early 
onset sepsis. Tartu, 2010. 
169. Jaanus Kahu. Kidney transplantation: Studies on donor risk factors and 
mycophenolate mofetil. Tartu, 2010.  
170.  Koit Reimand. Autoimmunity in reproductive failure: A study on as-
sociated autoantibodies and autoantigens. Tartu, 2010. 
171. Mart Kull. Impact of vitamin D and hypolactasia on bone mineral 
density: a population based study in Estonia. Tartu, 2010. 
172. Rael Laugesaar. Stroke in children – epidemiology and risk factors. 
Tartu, 2010.  
173.  Mark Braschinsky. Epidemiology and quality of life issues of hereditary 
spastic paraplegia in Estonia and implemention of genetic analysis in 
everyday neurologic practice. Tartu, 2010. 
174. Kadri Suija. Major depression in family medicine: associated factors, 
recurrence and possible intervention. Tartu, 2010. 
175. Jarno Habicht. Health care utilisation in Estonia: socioeconomic determi-
nants and financial burden of out-of-pocket payments. Tartu, 2010. 
176. Kristi Abram. The prevalence and risk factors of rosacea. Subjective 
disease perception of rosacea patients. Tartu, 2010. 
177. Malle Kuum. Mitochondrial and endoplasmic reticulum cation fluxes: 
Novel roles in cellular physiology. Tartu, 2010. 
178. Rita Teek. The genetic causes of early onset hearing loss in Estonian 
children. Tartu, 2010. 
134 
179. Daisy Volmer. The development of community pharmacy services in 
Estonia – public and professional perceptions 1993–2006. Tartu, 2010. 
180. Jelena Lissitsina. Cytogenetic causes in male infertility. Tartu, 2011. 
181.  Delia Lepik. Comparison of gunshot injuries caused from Tokarev, 
Makarov and Glock 19 pistols at different firing distances. Tartu, 2011. 
182.  Ene-Renate Pähkla. Factors related to the efficiency of treatment of 
advanced periodontitis. Tartu, 2011.  
183. Maarja Krass. L-Arginine pathways and antidepressant action. Tartu, 
2011.  
184.  Taavi Lai. Population health measures to support evidence-based  
health policy in Estonia. Tartu, 2011.  
185. Tiit Salum. Similarity and difference of temperature-dependence of the 
brain sodium pump in normal, different neuropathological, and aberrant 
conditions and its possible reasons. Tartu, 2011.  
186.  Tõnu Vooder. Molecular differences and similarities between histo-
logical subtypes of non-small cell lung cancer. Tartu, 2011.  
187.  Jelena Štšepetova. The characterisation of intestinal lactic acid bacteria 
using bacteriological, biochemical and molecular approaches. Tartu, 2011.  
188. Radko Avi. Natural polymorphisms and transmitted drug resistance in 
Estonian HIV-1 CRF06_cpx and its recombinant viruses. Tartu, 2011, 116 p. 
189.  Edward Laane. Multiparameter flow cytometry in haematological malig-
nancies. Tartu, 2011, 152 p. 
190.  Triin Jagomägi. A study of the genetic etiology of nonsyndromic cleft lip 
and palate. Tartu, 2011, 158 p. 
191.  Ivo Laidmäe. Fibrin glue of fish (Salmo salar) origin: immunological 
study and development of new pharmaceutical preparation. Tartu, 2012, 
150 p. 
192.  Ülle Parm. Early mucosal colonisation and its role in prediction of inva-
sive infection in neonates at risk of early onset sepsis. Tartu, 2012, 168 p. 
193.  Kaupo Teesalu. Autoantibodies against desmin and transglutaminase 2 in 
celiac disease: diagnostic and functional significance. Tartu, 2012, 142 p. 
194. Maksim Zagura. Biochemical, functional and structural profiling of 
arterial damage in atherosclerosis. Tartu, 2012, 162 p. 
195. Vivian Kont. Autoimmune regulator: characterization of thymic gene 
regulation and promoter methylation. Tartu, 2012, 134 p. 
196. Pirje Hütt. Functional properties, persistence, safety and efficacy of 
potential probiotic lactobacilli. Tartu, 2012, 246 p. 
197.  Innar Tõru. Serotonergic modulation of CCK-4- induced panic. Tartu, 
2012, 132 p. 
198.  Sigrid Vorobjov. Drug use, related risk behaviour and harm reduction 
interventions utilization among injecting drug users in Estonia: impli-
cations for drug policy. Tartu, 2012, 120 p. 
 
 
199.  Martin Serg. Therapeutic aspects of central haemodynamics, arterial 
stiffness and oxidative stress in hypertension. Tartu, 2012, 156 p.  
200. Jaanika Kumm. Molecular markers of articular tissues in early knee 
osteoarthritis: a population-based longitudinal study in middle-aged sub-
jects. Tartu, 2012, 159 p. 
201. Kertu Rünkorg. Functional changes of dopamine, endopioid and endo-
cannabinoid systems in CCK2 receptor deficient mice. Tartu, 2012, 125 p. 
202. Mai Blöndal. Changes in the baseline characteristics, management and 
outcomes of acute myocardial infarction in Estonia. Tartu, 2012, 127 p.        
203. Jana Lass. Epidemiological and clinical aspects of medicines use in 
children in Estonia. Tartu, 2012, 170 p. 
204. Kai Truusalu. Probiotic lactobacilli in experimental persistent Salmo-
nella infection. Tartu, 2013, 139 p.  
205. Oksana Jagur.  Temporomandibular joint diagnostic imaging in relation 
to pain and bone characteristics. Long-term results of arthroscopic treat-
ment. Tartu, 2013, 126 p. 
206. Katrin Sikk. Manganese-ephedrone intoxication – pathogenesis of neuro-
logical damage and clinical symptomatology. Tartu, 2013, 125 p. 
207. Kai Blöndal. Tuberculosis in Estonia with special emphasis on drug-
resistant tuberculosis: Notification rate, disease recurrence and mortality. 
Tartu, 2013, 151 p. 
208. Marju Puurand. Oxidative phosphorylation in different diseases of 
gastric mucosa. Tartu, 2013, 123 p.  
209. Aili Tagoma. Immune activation in female infertility: Significance of 
autoantibodies and inflammatory mediators. Tartu, 2013, 131 p. 
 
 
 
 
 
 
 
 
